MEK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O14545 | S327 | Sugiyama | TRAFD1 FLN29 | DHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQQAAS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O75676 | S196 | EPSD | RPS6KA4 MSK2 | VLTDFGLSKEFLTEEKERtFsFCGTIEYMAPEIIRSKTGHG |
| O75676 | S343 | EPSD | RPS6KA4 MSK2 | RsELDVGNFAEEFTRLEPVysPPGsPPPGDPRIFQGYsFVA |
| O75676 | S347 | EPSD | RPS6KA4 MSK2 | DVGNFAEEFTRLEPVysPPGsPPPGDPRIFQGYsFVAPsIL |
| O75676 | S360 | EPSD | RPS6KA4 MSK2 | PVysPPGsPPPGDPRIFQGYsFVAPsILFDHNNAVMTDGLE |
| O75676 | T568 | EPSD | RPS6KA4 MSK2 | KIIDFGFARLRPQSPGVPMQtPCFTLQYAAPELLAQQGYDE |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P04049 | S338 | EPSD|PSP | RAF1 RAF | RAPVsGtQEKNKIRPRGQRDssyyWEIEASEVMLSTRIGsG |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | Y364 | Sugiyama | ALDOA ALDA | tPsGQAGAAAsEsLFVsNHAy____________________ |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05787 | S74 | EPSD|PSP | KRT8 CYK8 | YGGASGMGGITAVtVNQSLLsPLVLEVDPNIQAVRTQEKEQ |
| P06401 | S294 | PSP | PGR NR3C3 | RFSAPRVALVEQDAPMAPGRsPLATTVMDFIHVPILPLNHA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10809 | T422 | Sugiyama | HSPD1 HSP60 | AVLKVGGtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGC |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P12956 | S77 | PSP | XRCC6 G22P1 | LTPFDMSIQCIQSVYISKIIssDRDLLAVVFYGTEKDKNSV |
| P12956 | S78 | PSP | XRCC6 G22P1 | TPFDMSIQCIQSVYISKIIssDRDLLAVVFYGTEKDKNSVN |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13797 | T117 | Sugiyama | PLS3 | INRKEGICALGGTsELssEGtQHsysEEEKyAFVNWINKAL |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P17066 | T224 | Sugiyama | HSPA6 HSP70B' | GGTFDVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFM |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17542 | S122 | SIGNOR|EPSD|PSP | TAL1 BHLHA17 SCL TCL5 | APAPASVTAELPGDGRMVQLsPPALAAPAAPGRALLYSLSQ |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | Y26 | Sugiyama | PGAM1 PGAMA CDABP0006 | LVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALR |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27361 | T202 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPK3 ERK1 PRKM3 | ICDFGLARIADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGY |
| P27361 | T207 | EPSD|PSP | MAPK3 ERK1 PRKM3 | LARIADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGYTKSID |
| P27361 | Y204 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPK3 ERK1 PRKM3 | DFGLARIADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGYTK |
| P27361 | Y210 | EPSD|PSP | MAPK3 ERK1 PRKM3 | IADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGYTKSIDIWS |
| P28482 | T185 | GPS6|SIGNOR|ELM|EPSD|PSP | MAPK1 ERK2 PRKM1 PRKM2 | ICDFGLARVADPDHDHtGFLtEyVAtRWyRAPEIMLNSKGY |
| P28482 | Y187 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPK1 ERK2 PRKM1 PRKM2 | DFGLARVADPDHDHtGFLtEyVAtRWyRAPEIMLNSKGYTK |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P32121 | T382 | SIGNOR | ARRB2 ARB2 ARR2 | APETDVPVDTNLIEFDTNYAtDDDIVFEDFARLRLKGMKDD |
| P34931 | T224 | Sugiyama | HSPA1L | GGTFDVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFV |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P35568 | S307 | SIGNOR | IRS1 | HHLNNPPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVR |
| P36507 | S222 | Sugiyama | MAP2K2 MEK2 MKK2 PRKMK2 | VNSRGEIKLCDFGVsGQLIDsMANsFVGtRSYMAPERLQGT |
| P36507 | S226 | Sugiyama | MAP2K2 MEK2 MKK2 PRKMK2 | GEIKLCDFGVsGQLIDsMANsFVGtRSYMAPERLQGTHYSV |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P45984 | S407 | ELM | MAPK9 JNK2 PRKM9 SAPK1A | PSQSSSINDISSMSTEQtLAsDTDSSLDASTGPLEGCR___ |
| P45984 | T404 | ELM | MAPK9 JNK2 PRKM9 SAPK1A | NATPSQSSSINDISSMSTEQtLAsDTDSSLDASTGPLEGCR |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P47712 | S724 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | NIDVIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFL |
| P48741 | T224 | Sugiyama | HSPA7 HSP70B | GGTFDVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFM |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49841 | Y216 | SIGNOR|ELM|iPTMNet|EPSD|PSP | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P53779 | T221 | ELM | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | CTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYK |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55211 | T125 | SIGNOR|iPTMNet|EPSD | CASP9 MCH6 | NLtPVVLRPEIRKPEVLRPEtPRPVDIGSGGFGDVGALEsL |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P85037 | S445 | Sugiyama | FOXK1 MNF | GLMsPRsGGLQtPECLsREGsPIPHDPEFGsKLASVPEYRY |
| Q00613 | S326 | EPSD|PSP | HSF1 HSTF1 | QsPRVEEAsPGRPssVDtLLsPtALIDsILREsEPAPAsVT |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q02750 | S218 | ELM|Sugiyama | MAP2K1 MEK1 PRKMK1 | VNSRGEIKLCDFGVsGQLIDsMANsFVGtRSYMsPERLQGT |
| Q02750 | S222 | Sugiyama | MAP2K1 MEK1 PRKMK1 | GEIKLCDFGVsGQLIDsMANsFVGtRSYMsPERLQGTHYSV |
| Q02750 | S24 | ELM | MAP2K1 MEK1 PRKMK1 | KKPTPIQLNPAPDGSAVNGtssAETNLEALQKKLEELELDE |
| Q02750 | S25 | ELM | MAP2K1 MEK1 PRKMK1 | KPTPIQLNPAPDGSAVNGtssAETNLEALQKKLEELELDEQ |
| Q02750 | S298 | ELM | MAP2K1 MEK1 PRKMK1 | QVEGDAAEtPPRPRtPGRPLssyGMDsRPPMAIFELLDYIV |
| Q02750 | S304 | SIGNOR|EPSD | MAP2K1 MEK1 PRKMK1 | AEtPPRPRtPGRPLssyGMDsRPPMAIFELLDYIVNEPPPK |
| Q02750 | T23 | ELM | MAP2K1 MEK1 PRKMK1 | KKKPTPIQLNPAPDGSAVNGtssAETNLEALQKKLEELELD |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q13009 | S329 | SIGNOR | TIAM1 | SNsMQGRRAKttQDVNAGEGsEFADsGIEGAtTDTDLLSRR |
| Q13112 | S410 | Sugiyama | CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7 | LNMRtPDtAKKTKsQtHRGssPGPRPVEGtPASRtQDPssP |
| Q13148 | T153 | PSP | TARDBP TDP43 | VQVKKDLKTGHSKGFGFVRFtEyETQVKVMSQRHMIDGRWC |
| Q13148 | Y155 | PSP | TARDBP TDP43 | VKKDLKTGHSKGFGFVRFtEyETQVKVMSQRHMIDGRWCDC |
| Q13158 | S194 | Sugiyama | FADD MORT1 GIG3 | ADLVQEVQQARDLQNRsGAMsPMsWNsDAsTSEAS______ |
| Q13158 | S197 | Sugiyama | FADD MORT1 GIG3 | VQEVQQARDLQNRsGAMsPMsWNsDAsTSEAS_________ |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q16539 | T180 | ELM | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | EDCELKILDFGLARHtDDEMtGyVAtRWYRAPEIMLNWMHY |
| Q16539 | Y182 | ELM | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | CELKILDFGLARHtDDEMtGyVAtRWYRAPEIMLNWMHYNQ |
| Q16626 | S163 | Sugiyama | MEA1 MEA | RTMAGVSLPAPGVPAWAREIsDAQWEDVVQKALQARQAsPA |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q6N021 | S1107 | SIGNOR | TET2 KIAA1546 Nbla00191 | SSEKTPTKRTAASVLNNFIEsPsKLLDtPIKNLLDTPVKTQ |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6UN15 | S496 | Sugiyama | FIP1L1 FIP1 RHE | DRERERTRERERERDHsPtPsVFNsDEERyRYREYAERGYE |
| Q6ZN28 | Y673 | PSP | MACC1 | VLTLVSEKVYDWKVLADVLGySHLSLEDFDQIQADKESEKV |
| Q6ZN28 | Y695 | PSP | MACC1 | HLSLEDFDQIQADKESEKVSyVIKKLKEDCHTERNTRKFLY |
| Q6ZN28 | Y793 | PSP | MACC1 | RGNTGDVAVEMMWKPAYDFLyTWSAHYGNNYRDVLQDLQSA |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N684 | S205 | Sugiyama | CPSF7 | IPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLPYF |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q96I24 | T561 | Sugiyama | FUBP3 FBP3 | PDYtMAWAEYYRQQVAFYGQtLGQAQAHsQEQ_________ |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9HAP2 | Y222 | PSP | MLXIP BHLHE36 KIAA0867 MIR MONDOA | EAITTEGKYWKSRIEIVIREyHKWRTYFKKRLQQHKDEDLS |
| Q9NPI6 | S525 | Sugiyama | DCP1A SMIF | SVFQQTVTRSSDLERKAssPsPLtIGtPEsQRKPSIILSKs |
| Q9NR19 | S30 | Sugiyama | ACSS2 ACAS2 | sGsGSRGQEEAGAGGRARsWsPPPEVsRSAHVPSLQRYREL |
| Q9NVD7 | S14 | EPSD | PARVA MXRA2 | _______MAtsPQKsPsVPKsPtPKsPPSRKKDDsFLGKLG |
| Q9NVD7 | S19 | EPSD | PARVA MXRA2 | __MAtsPQKsPsVPKsPtPKsPPSRKKDDsFLGKLGGtLAR |
| Q9NVD7 | S4 | EPSD | PARVA MXRA2 | _________________MAtsPQKsPsVPKsPtPKsPPSRK |
| Q9NVD7 | S8 | EPSD | PARVA MXRA2 | _____________MAtsPQKsPsVPKsPtPKsPPSRKKDDs |
| Q9NVD7 | T16 | EPSD | PARVA MXRA2 | _____MAtsPQKsPsVPKsPtPKsPPSRKKDDsFLGKLGGt |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UKV3 | S388 | Sugiyama | ACIN1 ACINUS KIAA0670 | EEEEREIKssQGLKEKsKsPsPPRLtEDRKKAsLVALPEQt |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S323 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RGEGDAPFsEPGttstQRPssPEtAtKQPssPYEDKDKDKK |
| Q9UQ35 | S876 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tsPQANEQsVtPQRRsCFEssPDPELKsRtPsRHsCsGssP |
| Q9UQ35 | T328 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APFsEPGttstQRPssPEtAtKQPssPYEDKDKDKKEKsAt |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle, Mitotic | R-HSA-69278 | 4.814140e-10 | 9.317 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.652153e-09 | 8.782 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.550304e-09 | 8.342 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.637429e-08 | 7.786 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.143189e-08 | 7.669 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.693526e-08 | 7.433 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.368814e-08 | 7.360 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.814257e-07 | 6.551 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.492828e-07 | 6.260 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.005655e-07 | 6.221 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.025367e-06 | 5.989 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.489675e-06 | 5.827 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.326193e-06 | 5.633 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.826162e-06 | 5.549 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.347098e-06 | 5.197 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.347098e-06 | 5.197 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.355849e-06 | 5.133 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.355849e-06 | 5.133 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.937865e-06 | 5.159 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.147824e-06 | 5.089 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.226937e-06 | 5.085 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.881471e-06 | 5.052 | 1 | 0 |
| Cell junction organization | R-HSA-446728 | 9.829586e-06 | 5.007 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.097156e-05 | 4.960 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.587081e-05 | 4.799 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.006447e-05 | 4.698 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.156753e-05 | 4.666 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.721383e-05 | 4.565 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.471706e-05 | 4.459 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.334534e-05 | 4.363 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.505647e-05 | 4.259 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.761130e-05 | 4.239 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.211279e-04 | 3.917 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.301728e-04 | 3.885 | 1 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.387474e-04 | 3.858 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.626077e-04 | 3.789 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.721682e-04 | 3.764 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.679457e-04 | 3.775 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.797044e-04 | 3.745 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.514916e-04 | 3.599 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.514916e-04 | 3.599 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.380545e-04 | 3.623 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.376335e-04 | 3.624 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.566435e-04 | 3.591 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.514916e-04 | 3.599 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.272918e-04 | 3.643 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.531447e-04 | 3.597 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.960591e-04 | 3.529 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.212535e-04 | 3.493 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.549577e-04 | 3.450 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.613902e-04 | 3.442 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.263345e-04 | 3.370 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.288863e-04 | 3.368 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.263345e-04 | 3.370 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.263345e-04 | 3.370 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.263345e-04 | 3.370 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.529245e-04 | 3.344 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.663762e-04 | 3.331 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.618849e-04 | 3.335 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.347865e-04 | 3.272 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.564712e-04 | 3.255 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.148523e-04 | 3.288 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.347865e-04 | 3.272 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.347865e-04 | 3.272 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.363534e-04 | 3.271 | 1 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.826206e-04 | 3.235 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.826206e-04 | 3.235 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.783305e-04 | 3.169 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.155337e-04 | 3.145 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.431817e-04 | 3.129 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.431817e-04 | 3.129 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.076535e-04 | 3.042 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.986814e-04 | 3.046 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.413023e-04 | 3.026 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.009050e-03 | 2.996 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.009050e-03 | 2.996 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.009050e-03 | 2.996 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.016932e-03 | 2.993 | 1 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.137205e-03 | 2.944 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.137205e-03 | 2.944 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.243597e-03 | 2.905 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.338403e-03 | 2.873 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.338403e-03 | 2.873 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.356735e-03 | 2.868 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.408787e-03 | 2.851 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.414748e-03 | 2.849 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.562351e-03 | 2.806 | 1 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.594690e-03 | 2.797 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.824126e-03 | 2.739 | 1 | 1 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.727199e-03 | 2.763 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.836462e-03 | 2.736 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.748759e-03 | 2.757 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.828175e-03 | 2.738 | 1 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.752009e-03 | 2.756 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.050345e-03 | 2.688 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.112006e-03 | 2.675 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.225763e-03 | 2.653 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.225763e-03 | 2.653 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.112006e-03 | 2.675 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.259872e-03 | 2.646 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.524586e-03 | 2.598 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.717203e-03 | 2.566 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.515447e-03 | 2.599 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.364754e-03 | 2.626 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.391487e-03 | 2.621 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.459556e-03 | 2.609 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.524586e-03 | 2.598 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.524586e-03 | 2.598 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.364754e-03 | 2.626 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.364754e-03 | 2.626 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.722665e-03 | 2.565 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.782635e-03 | 2.556 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.782635e-03 | 2.556 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.802103e-03 | 2.553 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.802103e-03 | 2.553 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.807445e-03 | 2.552 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.327558e-03 | 2.478 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.327558e-03 | 2.478 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.155680e-03 | 2.501 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.222255e-03 | 2.492 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.404617e-03 | 2.468 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.479277e-03 | 2.459 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.013954e-03 | 2.521 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.013954e-03 | 2.521 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.365849e-03 | 2.473 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.885839e-03 | 2.540 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.216619e-03 | 2.493 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.491291e-03 | 2.457 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.491665e-03 | 2.457 | 1 | 1 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.491665e-03 | 2.457 | 1 | 1 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.491665e-03 | 2.457 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.537622e-03 | 2.451 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.637359e-03 | 2.439 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.700438e-03 | 2.432 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.700438e-03 | 2.432 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.700438e-03 | 2.432 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.200829e-03 | 2.377 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.200829e-03 | 2.377 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.266143e-03 | 2.370 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.090982e-03 | 2.388 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.030313e-03 | 2.395 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.266604e-03 | 2.370 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.266604e-03 | 2.370 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.270299e-03 | 2.370 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.423104e-03 | 2.354 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.428975e-03 | 2.354 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.574892e-03 | 2.340 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 4.582649e-03 | 2.339 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.831801e-03 | 2.316 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.831801e-03 | 2.316 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.845437e-03 | 2.315 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.030688e-03 | 2.298 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 5.173326e-03 | 2.286 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.173326e-03 | 2.286 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.173326e-03 | 2.286 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.486585e-03 | 2.261 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.526847e-03 | 2.258 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.151575e-03 | 2.211 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.151575e-03 | 2.211 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.151575e-03 | 2.211 | 1 | 1 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.151575e-03 | 2.211 | 1 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.860256e-03 | 2.164 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.311951e-03 | 2.200 | 1 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.992710e-03 | 2.155 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.992710e-03 | 2.155 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.992710e-03 | 2.155 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.993320e-03 | 2.155 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.381190e-03 | 2.132 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.637854e-03 | 2.064 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.084624e-03 | 2.092 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.627980e-03 | 2.118 | 1 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.084624e-03 | 2.092 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.451205e-03 | 2.073 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.356573e-03 | 2.078 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.133043e-03 | 2.090 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.699889e-03 | 2.060 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.605948e-03 | 2.119 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.217561e-03 | 2.085 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.564637e-03 | 2.121 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.560549e-03 | 2.121 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.637854e-03 | 2.064 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.851440e-03 | 2.105 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.731693e-03 | 2.059 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.731693e-03 | 2.059 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.560549e-03 | 2.121 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.731693e-03 | 2.059 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.731693e-03 | 2.059 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.841901e-03 | 2.053 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.131226e-03 | 2.039 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.209018e-03 | 2.036 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.470557e-03 | 2.024 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.470557e-03 | 2.024 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.502307e-03 | 2.022 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.530387e-03 | 2.021 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 9.980488e-03 | 2.001 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.017299e-02 | 1.993 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.111487e-02 | 1.954 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.022815e-02 | 1.990 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.017299e-02 | 1.993 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.017299e-02 | 1.993 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.089449e-02 | 1.963 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.820885e-03 | 2.008 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.111487e-02 | 1.954 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.166081e-02 | 1.933 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.111487e-02 | 1.954 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.995737e-03 | 2.000 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.111487e-02 | 1.954 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.017299e-02 | 1.993 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.985721e-03 | 2.001 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 9.960989e-03 | 2.002 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.022815e-02 | 1.990 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.171311e-02 | 1.931 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.173016e-02 | 1.931 | 1 | 1 |
| Deubiquitination | R-HSA-5688426 | 1.180608e-02 | 1.928 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.215616e-02 | 1.915 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.295648e-02 | 1.888 | 1 | 1 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.367224e-02 | 1.864 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.374620e-02 | 1.862 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.397197e-02 | 1.855 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.397197e-02 | 1.855 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.397197e-02 | 1.855 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.397197e-02 | 1.855 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.405169e-02 | 1.852 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.405595e-02 | 1.852 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.405595e-02 | 1.852 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.447225e-02 | 1.839 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.472734e-02 | 1.832 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.534351e-02 | 1.814 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.534351e-02 | 1.814 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.548275e-02 | 1.810 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.548275e-02 | 1.810 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.793912e-02 | 1.746 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.559648e-02 | 1.807 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.571278e-02 | 1.804 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.571278e-02 | 1.804 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.750000e-02 | 1.757 | 1 | 1 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.805412e-02 | 1.743 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.773746e-02 | 1.751 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.571278e-02 | 1.804 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.942197e-02 | 1.712 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.621717e-02 | 1.790 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.750000e-02 | 1.757 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.733406e-02 | 1.761 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.564013e-02 | 1.806 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.750000e-02 | 1.757 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.723583e-02 | 1.764 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.793912e-02 | 1.746 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.873883e-02 | 1.727 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.750000e-02 | 1.757 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.942197e-02 | 1.712 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.829879e-02 | 1.738 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.829879e-02 | 1.738 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.053101e-02 | 1.688 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.116387e-02 | 1.674 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.117391e-02 | 1.674 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.141316e-02 | 1.669 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.148061e-02 | 1.668 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.148289e-02 | 1.668 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.148289e-02 | 1.668 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.164147e-02 | 1.665 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.164147e-02 | 1.665 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.164147e-02 | 1.665 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.164147e-02 | 1.665 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.164147e-02 | 1.665 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.164147e-02 | 1.665 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.246853e-02 | 1.648 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.246853e-02 | 1.648 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.246853e-02 | 1.648 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.267102e-02 | 1.645 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.267102e-02 | 1.645 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.267102e-02 | 1.645 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.283996e-02 | 1.641 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.331016e-02 | 1.632 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.368666e-02 | 1.625 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.368666e-02 | 1.625 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.420368e-02 | 1.616 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.462803e-02 | 1.609 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.463476e-02 | 1.608 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.504732e-02 | 1.601 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.542364e-02 | 1.595 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.542364e-02 | 1.595 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.542364e-02 | 1.595 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.544992e-02 | 1.594 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.598561e-02 | 1.585 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.598561e-02 | 1.585 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.603696e-02 | 1.584 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.608331e-02 | 1.584 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.617797e-02 | 1.582 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.702870e-02 | 1.568 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.752525e-02 | 1.560 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.756206e-02 | 1.560 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.756206e-02 | 1.560 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.779892e-02 | 1.556 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.792009e-02 | 1.554 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.623490e-02 | 1.441 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.492854e-02 | 1.457 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.853722e-02 | 1.545 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.119058e-02 | 1.506 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.172475e-02 | 1.499 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.419165e-02 | 1.466 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.678274e-02 | 1.434 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.757829e-02 | 1.425 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.697401e-02 | 1.432 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.119058e-02 | 1.506 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.697401e-02 | 1.432 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.696774e-02 | 1.432 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.963948e-02 | 1.528 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.502883e-02 | 1.456 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.260982e-02 | 1.487 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.399989e-02 | 1.469 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 3.623490e-02 | 1.441 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.119058e-02 | 1.506 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.119058e-02 | 1.506 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.399989e-02 | 1.469 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.119058e-02 | 1.506 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.853722e-02 | 1.545 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.119058e-02 | 1.506 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.895229e-02 | 1.538 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.153894e-02 | 1.501 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.352137e-02 | 1.475 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.260982e-02 | 1.487 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.399989e-02 | 1.469 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.780948e-02 | 1.422 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.852390e-02 | 1.414 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.852390e-02 | 1.414 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.942636e-02 | 1.404 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.942636e-02 | 1.404 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.942636e-02 | 1.404 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.942636e-02 | 1.404 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.949994e-02 | 1.403 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.956231e-02 | 1.403 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 4.165783e-02 | 1.380 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.165783e-02 | 1.380 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 4.165783e-02 | 1.380 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.234501e-02 | 1.373 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.234501e-02 | 1.373 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.331015e-02 | 1.363 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.338784e-02 | 1.363 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.338784e-02 | 1.363 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.338784e-02 | 1.363 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.400777e-02 | 1.356 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.484896e-02 | 1.348 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.531952e-02 | 1.344 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.553410e-02 | 1.342 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.553410e-02 | 1.342 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.618001e-02 | 1.336 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.618001e-02 | 1.336 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.618001e-02 | 1.336 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.618001e-02 | 1.336 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.618001e-02 | 1.336 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.618001e-02 | 1.336 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.618001e-02 | 1.336 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.636966e-02 | 1.334 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.636966e-02 | 1.334 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.636966e-02 | 1.334 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.666153e-02 | 1.331 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.684376e-02 | 1.329 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.684376e-02 | 1.329 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.717370e-02 | 1.326 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.776534e-02 | 1.321 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.776534e-02 | 1.321 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.776534e-02 | 1.321 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 4.776534e-02 | 1.321 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 4.829048e-02 | 1.316 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 4.829048e-02 | 1.316 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 4.829048e-02 | 1.316 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.832260e-02 | 1.316 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.832260e-02 | 1.316 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.842487e-02 | 1.315 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.842487e-02 | 1.315 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.842487e-02 | 1.315 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.904563e-02 | 1.309 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.046552e-02 | 1.297 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.046552e-02 | 1.297 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.046552e-02 | 1.297 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.046552e-02 | 1.297 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.046552e-02 | 1.297 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.062289e-02 | 1.296 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.062289e-02 | 1.296 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.042960e-02 | 1.219 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.042960e-02 | 1.219 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.042960e-02 | 1.219 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.409159e-02 | 1.130 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.346459e-02 | 1.272 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.126420e-02 | 1.213 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.956083e-02 | 1.158 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.956083e-02 | 1.158 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.833461e-02 | 1.106 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.833461e-02 | 1.106 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.821053e-02 | 1.235 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.233501e-02 | 1.205 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.734437e-02 | 1.242 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.461229e-02 | 1.127 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.955322e-02 | 1.158 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.734437e-02 | 1.242 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.346459e-02 | 1.272 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.903907e-02 | 1.229 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.042960e-02 | 1.219 | 1 | 1 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.979288e-02 | 1.223 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.979288e-02 | 1.223 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.979288e-02 | 1.223 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.111664e-02 | 1.148 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.955322e-02 | 1.158 | 1 | 0 |
| DNA Repair | R-HSA-73894 | 6.452952e-02 | 1.190 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.984702e-02 | 1.223 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.409159e-02 | 1.130 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.833461e-02 | 1.106 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.470915e-02 | 1.189 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.984507e-02 | 1.156 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.984507e-02 | 1.156 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.233501e-02 | 1.205 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.571733e-02 | 1.121 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.595030e-02 | 1.181 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.425419e-02 | 1.266 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.661473e-02 | 1.116 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.363425e-02 | 1.133 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.409159e-02 | 1.130 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.509729e-02 | 1.259 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.509729e-02 | 1.259 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 5.503278e-02 | 1.259 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.425419e-02 | 1.266 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.272678e-02 | 1.278 | 1 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.042960e-02 | 1.219 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.461229e-02 | 1.127 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.409159e-02 | 1.130 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.956083e-02 | 1.158 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.509729e-02 | 1.259 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.853722e-02 | 1.233 | 1 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.662778e-02 | 1.176 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.662778e-02 | 1.176 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 6.042960e-02 | 1.219 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.841493e-02 | 1.165 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.509729e-02 | 1.259 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.470915e-02 | 1.189 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.762356e-02 | 1.239 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.042960e-02 | 1.219 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.420757e-02 | 1.266 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.579502e-02 | 1.120 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.579502e-02 | 1.120 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.509729e-02 | 1.259 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 5.425419e-02 | 1.266 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.263193e-02 | 1.139 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.640565e-02 | 1.117 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.461229e-02 | 1.127 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.904269e-02 | 1.102 | 1 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.051297e-02 | 1.094 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.076924e-02 | 1.093 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.076924e-02 | 1.093 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.076924e-02 | 1.093 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.076924e-02 | 1.093 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.237512e-02 | 1.084 | 1 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.327051e-02 | 1.080 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.547460e-02 | 1.068 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.547460e-02 | 1.068 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.579237e-02 | 1.067 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.579237e-02 | 1.067 | 1 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.684961e-02 | 1.061 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.684961e-02 | 1.061 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.862568e-02 | 1.052 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.862568e-02 | 1.052 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.045835e-02 | 1.044 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.060094e-02 | 1.043 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.181517e-02 | 1.037 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.254743e-02 | 1.034 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.254743e-02 | 1.034 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.254743e-02 | 1.034 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.254743e-02 | 1.034 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.268029e-02 | 1.033 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.288134e-02 | 1.032 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.288134e-02 | 1.032 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 9.425178e-02 | 1.026 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 9.425178e-02 | 1.026 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 9.425178e-02 | 1.026 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.425178e-02 | 1.026 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.425178e-02 | 1.026 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.425178e-02 | 1.026 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 9.425178e-02 | 1.026 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.425178e-02 | 1.026 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 9.425178e-02 | 1.026 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 9.425178e-02 | 1.026 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.425178e-02 | 1.026 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.470131e-02 | 1.024 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.503746e-02 | 1.022 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.589046e-02 | 1.018 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.615013e-02 | 1.017 | 1 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.621680e-02 | 1.017 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.621680e-02 | 1.017 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.621680e-02 | 1.017 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.621680e-02 | 1.017 | 1 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.621680e-02 | 1.017 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.655288e-02 | 1.015 | 1 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.722726e-02 | 1.012 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.756371e-02 | 1.011 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.758002e-02 | 1.011 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.786674e-02 | 1.009 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.786674e-02 | 1.009 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 9.786674e-02 | 1.009 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.786674e-02 | 1.009 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.874921e-02 | 1.005 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.874921e-02 | 1.005 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.874921e-02 | 1.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.874921e-02 | 1.005 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.958377e-02 | 1.002 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.013414e-01 | 0.994 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.013414e-01 | 0.994 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.013414e-01 | 0.994 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.013414e-01 | 0.994 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.013414e-01 | 0.994 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.013414e-01 | 0.994 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.039160e-01 | 0.983 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.039160e-01 | 0.983 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.039160e-01 | 0.983 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.039160e-01 | 0.983 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.050898e-01 | 0.978 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.051546e-01 | 0.978 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.059789e-01 | 0.975 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.059789e-01 | 0.975 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.073002e-01 | 0.969 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.073002e-01 | 0.969 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.080732e-01 | 0.966 | 1 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.080977e-01 | 0.966 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.086132e-01 | 0.964 | 1 | 0 |
| Hemostasis | R-HSA-109582 | 1.087347e-01 | 0.964 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.117594e-01 | 0.952 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.117594e-01 | 0.952 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.117594e-01 | 0.952 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.129354e-01 | 0.947 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.154967e-01 | 0.937 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.163261e-01 | 0.934 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.163261e-01 | 0.934 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.177591e-01 | 0.929 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.379961e-01 | 0.860 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.379961e-01 | 0.860 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.379961e-01 | 0.860 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.379961e-01 | 0.860 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.379961e-01 | 0.860 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.379961e-01 | 0.860 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.796302e-01 | 0.746 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.796302e-01 | 0.746 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 1.796302e-01 | 0.746 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 1.796302e-01 | 0.746 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.192559e-01 | 0.659 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 2.192559e-01 | 0.659 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.192559e-01 | 0.659 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 2.192559e-01 | 0.659 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 2.192559e-01 | 0.659 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.192559e-01 | 0.659 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.192559e-01 | 0.659 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.198559e-01 | 0.921 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.198559e-01 | 0.921 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 1.198559e-01 | 0.921 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.198559e-01 | 0.921 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.363471e-01 | 0.865 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.532994e-01 | 0.814 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.532994e-01 | 0.814 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.532994e-01 | 0.814 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.706300e-01 | 0.768 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.882628e-01 | 0.725 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.882628e-01 | 0.725 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.285793e-01 | 0.891 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.285793e-01 | 0.891 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.061285e-01 | 0.686 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.061285e-01 | 0.686 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.629596e-01 | 0.788 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.479659e-01 | 0.830 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.123580e-01 | 0.673 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.327242e-01 | 0.877 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.327242e-01 | 0.877 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.247139e-01 | 0.904 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.158863e-01 | 0.666 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.326094e-01 | 0.633 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.625405e-01 | 0.789 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.665030e-01 | 0.779 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.061285e-01 | 0.686 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.999254e-01 | 0.699 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.999254e-01 | 0.699 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.996997e-01 | 0.700 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.996997e-01 | 0.700 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.479659e-01 | 0.830 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.882628e-01 | 0.725 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.540610e-01 | 0.812 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.198559e-01 | 0.921 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.882628e-01 | 0.725 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.302911e-01 | 0.885 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.400788e-01 | 0.854 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.457744e-01 | 0.836 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.996997e-01 | 0.700 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.793399e-01 | 0.746 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.363471e-01 | 0.865 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.051480e-01 | 0.688 | 1 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.218041e-01 | 0.914 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.400788e-01 | 0.854 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.218041e-01 | 0.914 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.379961e-01 | 0.860 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 2.192559e-01 | 0.659 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.192559e-01 | 0.659 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.198559e-01 | 0.921 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.198559e-01 | 0.921 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.532994e-01 | 0.814 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.532994e-01 | 0.814 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.706300e-01 | 0.768 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.706300e-01 | 0.768 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.512045e-01 | 0.820 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.629596e-01 | 0.788 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.479659e-01 | 0.830 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.571323e-01 | 0.804 | 1 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.255492e-01 | 0.901 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.186405e-01 | 0.926 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.186405e-01 | 0.926 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.309361e-01 | 0.883 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.289352e-01 | 0.890 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.289352e-01 | 0.890 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.424230e-01 | 0.846 | 1 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.830453e-01 | 0.737 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.378120e-01 | 0.861 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.424230e-01 | 0.846 | 1 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.872314e-01 | 0.728 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.564198e-01 | 0.806 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.251832e-01 | 0.647 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.299506e-01 | 0.886 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.141790e-01 | 0.669 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.996997e-01 | 0.700 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.123580e-01 | 0.673 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.858122e-01 | 0.731 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.572466e-01 | 0.803 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.653791e-01 | 0.782 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.430451e-01 | 0.845 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.861226e-01 | 0.730 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 1.712036e-01 | 0.766 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.773178e-01 | 0.751 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.996997e-01 | 0.700 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.255492e-01 | 0.901 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.302911e-01 | 0.885 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.665030e-01 | 0.779 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.125263e-01 | 0.673 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 2.192559e-01 | 0.659 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.532994e-01 | 0.814 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.706300e-01 | 0.768 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.882628e-01 | 0.725 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.553040e-01 | 0.809 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.711767e-01 | 0.767 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.930508e-01 | 0.714 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.397361e-01 | 0.855 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.765717e-01 | 0.753 | 1 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.241635e-01 | 0.649 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.749767e-01 | 0.757 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.228435e-01 | 0.652 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.206376e-01 | 0.656 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.982074e-01 | 0.703 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.624567e-01 | 0.789 | 1 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.363471e-01 | 0.865 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.241635e-01 | 0.649 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.185592e-01 | 0.926 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.571323e-01 | 0.804 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.373039e-01 | 0.862 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.116611e-01 | 0.674 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.438140e-01 | 0.842 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.711780e-01 | 0.767 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.218041e-01 | 0.914 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.706300e-01 | 0.768 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.061285e-01 | 0.686 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 2.061285e-01 | 0.686 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.749767e-01 | 0.757 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.957275e-01 | 0.708 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.518796e-01 | 0.819 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.014861e-01 | 0.696 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.255492e-01 | 0.901 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.176303e-01 | 0.662 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.051480e-01 | 0.688 | 1 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.262204e-01 | 0.899 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.996997e-01 | 0.700 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.198559e-01 | 0.921 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 1.363471e-01 | 0.865 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.706300e-01 | 0.768 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.241635e-01 | 0.649 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.327242e-01 | 0.877 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.930508e-01 | 0.714 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.744867e-01 | 0.758 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.096433e-01 | 0.679 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.005589e-01 | 0.698 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.891092e-01 | 0.723 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.262959e-01 | 0.645 | 1 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.311067e-01 | 0.882 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.160211e-01 | 0.666 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.360545e-01 | 0.627 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.793399e-01 | 0.746 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.019283e-01 | 0.695 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.457744e-01 | 0.836 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.532994e-01 | 0.814 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.218041e-01 | 0.914 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.872314e-01 | 0.728 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.872314e-01 | 0.728 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.711767e-01 | 0.767 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.274851e-01 | 0.895 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.251832e-01 | 0.647 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.315974e-01 | 0.635 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.185592e-01 | 0.926 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.397361e-01 | 0.855 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.061285e-01 | 0.686 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.951320e-01 | 0.710 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 1.828572e-01 | 0.738 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.368347e-01 | 0.626 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.368543e-01 | 0.626 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.371915e-01 | 0.625 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.381529e-01 | 0.623 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 2.400858e-01 | 0.620 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.423099e-01 | 0.616 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.423099e-01 | 0.616 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.423099e-01 | 0.616 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.423099e-01 | 0.616 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.423099e-01 | 0.616 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.423099e-01 | 0.616 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.426989e-01 | 0.615 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 2.444764e-01 | 0.612 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.471596e-01 | 0.607 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 2.476538e-01 | 0.606 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.486785e-01 | 0.604 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.491944e-01 | 0.603 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.512454e-01 | 0.600 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.557992e-01 | 0.592 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.557992e-01 | 0.592 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.569698e-01 | 0.590 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.569698e-01 | 0.590 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.569698e-01 | 0.590 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.569698e-01 | 0.590 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.569698e-01 | 0.590 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.569698e-01 | 0.590 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.569698e-01 | 0.590 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.569698e-01 | 0.590 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 2.569698e-01 | 0.590 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.580336e-01 | 0.588 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.581344e-01 | 0.588 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.583893e-01 | 0.588 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.605150e-01 | 0.584 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.605150e-01 | 0.584 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.605150e-01 | 0.584 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.605150e-01 | 0.584 | 1 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.605150e-01 | 0.584 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.605150e-01 | 0.584 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.613929e-01 | 0.583 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.644395e-01 | 0.578 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.667318e-01 | 0.574 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.676635e-01 | 0.572 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.676635e-01 | 0.572 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.689136e-01 | 0.570 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.709562e-01 | 0.567 | 1 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.717889e-01 | 0.566 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.723001e-01 | 0.565 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.770098e-01 | 0.558 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.770098e-01 | 0.558 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.770098e-01 | 0.558 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.787308e-01 | 0.555 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.787308e-01 | 0.555 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.787308e-01 | 0.555 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.787308e-01 | 0.555 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.787308e-01 | 0.555 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.787308e-01 | 0.555 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.797707e-01 | 0.553 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.797707e-01 | 0.553 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.798659e-01 | 0.553 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.806456e-01 | 0.552 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.890480e-01 | 0.539 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.906947e-01 | 0.537 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.928642e-01 | 0.533 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.928642e-01 | 0.533 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.928642e-01 | 0.533 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.928642e-01 | 0.533 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.928642e-01 | 0.533 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.928642e-01 | 0.533 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.928642e-01 | 0.533 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.928642e-01 | 0.533 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.928642e-01 | 0.533 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.928642e-01 | 0.533 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.937096e-01 | 0.532 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.016749e-01 | 0.520 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.037516e-01 | 0.517 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.044322e-01 | 0.517 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.044322e-01 | 0.517 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.044322e-01 | 0.517 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.054112e-01 | 0.515 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.105697e-01 | 0.508 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.145470e-01 | 0.502 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.150251e-01 | 0.502 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.150251e-01 | 0.502 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.150251e-01 | 0.502 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.150251e-01 | 0.502 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.178372e-01 | 0.498 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.178372e-01 | 0.498 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.201099e-01 | 0.495 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.270266e-01 | 0.485 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.270266e-01 | 0.485 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.270266e-01 | 0.485 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.270266e-01 | 0.485 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.270266e-01 | 0.485 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.270266e-01 | 0.485 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.270266e-01 | 0.485 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.270266e-01 | 0.485 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.270266e-01 | 0.485 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.270266e-01 | 0.485 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.270266e-01 | 0.485 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.270266e-01 | 0.485 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.283754e-01 | 0.484 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.312499e-01 | 0.480 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.312499e-01 | 0.480 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.312499e-01 | 0.480 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.317410e-01 | 0.479 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.330288e-01 | 0.478 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.330288e-01 | 0.478 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.330288e-01 | 0.478 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 3.330288e-01 | 0.478 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 3.330288e-01 | 0.478 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.330288e-01 | 0.478 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.354784e-01 | 0.474 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 3.438699e-01 | 0.464 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.459520e-01 | 0.461 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.477377e-01 | 0.459 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.482984e-01 | 0.458 | 1 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.508933e-01 | 0.455 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.508933e-01 | 0.455 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.508933e-01 | 0.455 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.508933e-01 | 0.455 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 3.508933e-01 | 0.455 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.508933e-01 | 0.455 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.508933e-01 | 0.455 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.546045e-01 | 0.450 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.570611e-01 | 0.447 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.570611e-01 | 0.447 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.577288e-01 | 0.446 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.595406e-01 | 0.444 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.595406e-01 | 0.444 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.595406e-01 | 0.444 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.595406e-01 | 0.444 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 3.595406e-01 | 0.444 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.595406e-01 | 0.444 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 3.595406e-01 | 0.444 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.595406e-01 | 0.444 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.595406e-01 | 0.444 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.595406e-01 | 0.444 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.595406e-01 | 0.444 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.618499e-01 | 0.441 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.632332e-01 | 0.440 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.632332e-01 | 0.440 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.660770e-01 | 0.436 | 1 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.681674e-01 | 0.434 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.685901e-01 | 0.433 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.685901e-01 | 0.433 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.685901e-01 | 0.433 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.718062e-01 | 0.430 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 3.729263e-01 | 0.428 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.753008e-01 | 0.426 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.753008e-01 | 0.426 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.753008e-01 | 0.426 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.816681e-01 | 0.418 | 1 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.838420e-01 | 0.416 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.846619e-01 | 0.415 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.846619e-01 | 0.415 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.860936e-01 | 0.413 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.860936e-01 | 0.413 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.860936e-01 | 0.413 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.860936e-01 | 0.413 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.874227e-01 | 0.412 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.904855e-01 | 0.408 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.904855e-01 | 0.408 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.904855e-01 | 0.408 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.904855e-01 | 0.408 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.904855e-01 | 0.408 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.904855e-01 | 0.408 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.904855e-01 | 0.408 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.904855e-01 | 0.408 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.904855e-01 | 0.408 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.925535e-01 | 0.406 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.978833e-01 | 0.400 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.033814e-01 | 0.394 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.033814e-01 | 0.394 | 1 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.110261e-01 | 0.386 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.158144e-01 | 0.381 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.199371e-01 | 0.377 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.199371e-01 | 0.377 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.199371e-01 | 0.377 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.199371e-01 | 0.377 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.199371e-01 | 0.377 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.199371e-01 | 0.377 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.199371e-01 | 0.377 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.199371e-01 | 0.377 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.199371e-01 | 0.377 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.199371e-01 | 0.377 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.204333e-01 | 0.376 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.204333e-01 | 0.376 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 4.204333e-01 | 0.376 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.212696e-01 | 0.375 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.233589e-01 | 0.373 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.240785e-01 | 0.373 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.273223e-01 | 0.369 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.273223e-01 | 0.369 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.308750e-01 | 0.366 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.372320e-01 | 0.359 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.372320e-01 | 0.359 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.479673e-01 | 0.349 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.479673e-01 | 0.349 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.479673e-01 | 0.349 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.479673e-01 | 0.349 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.479673e-01 | 0.349 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.479673e-01 | 0.349 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.479673e-01 | 0.349 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.479673e-01 | 0.349 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.479673e-01 | 0.349 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.479673e-01 | 0.349 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.479673e-01 | 0.349 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.498695e-01 | 0.347 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.498695e-01 | 0.347 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 4.507594e-01 | 0.346 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.537620e-01 | 0.343 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.537620e-01 | 0.343 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.689156e-01 | 0.329 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.700101e-01 | 0.328 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.700101e-01 | 0.328 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 4.700101e-01 | 0.328 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.700101e-01 | 0.328 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.712189e-01 | 0.327 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 4.721726e-01 | 0.326 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.724517e-01 | 0.326 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.746446e-01 | 0.324 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.746446e-01 | 0.324 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.746446e-01 | 0.324 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.746446e-01 | 0.324 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.746446e-01 | 0.324 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.746446e-01 | 0.324 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.746446e-01 | 0.324 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.746446e-01 | 0.324 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.746446e-01 | 0.324 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.746446e-01 | 0.324 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 4.746446e-01 | 0.324 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.746446e-01 | 0.324 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.746446e-01 | 0.324 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 4.746446e-01 | 0.324 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.746446e-01 | 0.324 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.751778e-01 | 0.323 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.790529e-01 | 0.320 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.859650e-01 | 0.313 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.859650e-01 | 0.313 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.876294e-01 | 0.312 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.876294e-01 | 0.312 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.876428e-01 | 0.312 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.969184e-01 | 0.304 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.000343e-01 | 0.301 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.000343e-01 | 0.301 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 5.000343e-01 | 0.301 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.000343e-01 | 0.301 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.000343e-01 | 0.301 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.008024e-01 | 0.300 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.040545e-01 | 0.298 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.169584e-01 | 0.287 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.176342e-01 | 0.286 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.189857e-01 | 0.285 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.214721e-01 | 0.283 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.222252e-01 | 0.282 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.237481e-01 | 0.281 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.240859e-01 | 0.281 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.241984e-01 | 0.281 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.241984e-01 | 0.281 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.241984e-01 | 0.281 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.241984e-01 | 0.281 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.241984e-01 | 0.281 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.241984e-01 | 0.281 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.243467e-01 | 0.280 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.319824e-01 | 0.274 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.319824e-01 | 0.274 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.319824e-01 | 0.274 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.450864e-01 | 0.264 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.466839e-01 | 0.262 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.466839e-01 | 0.262 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.471960e-01 | 0.262 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.471960e-01 | 0.262 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.471960e-01 | 0.262 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.471960e-01 | 0.262 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.471960e-01 | 0.262 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.471960e-01 | 0.262 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.471960e-01 | 0.262 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.471960e-01 | 0.262 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.471960e-01 | 0.262 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.471960e-01 | 0.262 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.471960e-01 | 0.262 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.471960e-01 | 0.262 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.471960e-01 | 0.262 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.492024e-01 | 0.260 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.492024e-01 | 0.260 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.511057e-01 | 0.259 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.590702e-01 | 0.253 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.590702e-01 | 0.253 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.610590e-01 | 0.251 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.610590e-01 | 0.251 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.610590e-01 | 0.251 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.685326e-01 | 0.245 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.685326e-01 | 0.245 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.690833e-01 | 0.245 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.690833e-01 | 0.245 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.690833e-01 | 0.245 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.690833e-01 | 0.245 | 1 | 1 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.690833e-01 | 0.245 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.690833e-01 | 0.245 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.690833e-01 | 0.245 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.690833e-01 | 0.245 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.690833e-01 | 0.245 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.690833e-01 | 0.245 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.751049e-01 | 0.240 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.751049e-01 | 0.240 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.815120e-01 | 0.235 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.842111e-01 | 0.233 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.878822e-01 | 0.231 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.888199e-01 | 0.230 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.888199e-01 | 0.230 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 5.888199e-01 | 0.230 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.899139e-01 | 0.229 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.899139e-01 | 0.229 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.899139e-01 | 0.229 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.899139e-01 | 0.229 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.899139e-01 | 0.229 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.899139e-01 | 0.229 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.899139e-01 | 0.229 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.899139e-01 | 0.229 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.899139e-01 | 0.229 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.924579e-01 | 0.227 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.973227e-01 | 0.224 | 1 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.975203e-01 | 0.224 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.022031e-01 | 0.220 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.022031e-01 | 0.220 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.023045e-01 | 0.220 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.097388e-01 | 0.215 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.097388e-01 | 0.215 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.097388e-01 | 0.215 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.097388e-01 | 0.215 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.097388e-01 | 0.215 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.097388e-01 | 0.215 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.097388e-01 | 0.215 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.097388e-01 | 0.215 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.105095e-01 | 0.214 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.137862e-01 | 0.212 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.148106e-01 | 0.211 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.152545e-01 | 0.211 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.157376e-01 | 0.211 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.192809e-01 | 0.208 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.279750e-01 | 0.202 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.279750e-01 | 0.202 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.279750e-01 | 0.202 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.279750e-01 | 0.202 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.283428e-01 | 0.202 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.286064e-01 | 0.202 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 6.286064e-01 | 0.202 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.286064e-01 | 0.202 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.286064e-01 | 0.202 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.286064e-01 | 0.202 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.286064e-01 | 0.202 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.286064e-01 | 0.202 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.286064e-01 | 0.202 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.286064e-01 | 0.202 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.286064e-01 | 0.202 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.403659e-01 | 0.194 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.423505e-01 | 0.192 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.443422e-01 | 0.191 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.443422e-01 | 0.191 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.465629e-01 | 0.189 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.465629e-01 | 0.189 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.465629e-01 | 0.189 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.465629e-01 | 0.189 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.465629e-01 | 0.189 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.465629e-01 | 0.189 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.500208e-01 | 0.187 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.506588e-01 | 0.187 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.524295e-01 | 0.185 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.524295e-01 | 0.185 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.541396e-01 | 0.184 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 6.566879e-01 | 0.183 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.576110e-01 | 0.182 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.577920e-01 | 0.182 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 6.577920e-01 | 0.182 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.636523e-01 | 0.178 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.636523e-01 | 0.178 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.636523e-01 | 0.178 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.636523e-01 | 0.178 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.636523e-01 | 0.178 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.636523e-01 | 0.178 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.636523e-01 | 0.178 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.636523e-01 | 0.178 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.636523e-01 | 0.178 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.636523e-01 | 0.178 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.636523e-01 | 0.178 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.637420e-01 | 0.178 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.641685e-01 | 0.178 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.650947e-01 | 0.177 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.714388e-01 | 0.173 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.731493e-01 | 0.172 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.755859e-01 | 0.170 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.755859e-01 | 0.170 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.755859e-01 | 0.170 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.755859e-01 | 0.170 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.799164e-01 | 0.168 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.799164e-01 | 0.168 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.799164e-01 | 0.168 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.799164e-01 | 0.168 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.799164e-01 | 0.168 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.799164e-01 | 0.168 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.799164e-01 | 0.168 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.799164e-01 | 0.168 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 6.866855e-01 | 0.163 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.900613e-01 | 0.161 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.913791e-01 | 0.160 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.913791e-01 | 0.160 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.939497e-01 | 0.159 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.953950e-01 | 0.158 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.953950e-01 | 0.158 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 6.953950e-01 | 0.158 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.953950e-01 | 0.158 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.953950e-01 | 0.158 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.953950e-01 | 0.158 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.953950e-01 | 0.158 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.953950e-01 | 0.158 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.955040e-01 | 0.158 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.974712e-01 | 0.156 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.974712e-01 | 0.156 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.008909e-01 | 0.154 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.008909e-01 | 0.154 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.079475e-01 | 0.150 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.101259e-01 | 0.149 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.101259e-01 | 0.149 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.101259e-01 | 0.149 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.101259e-01 | 0.149 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.101259e-01 | 0.149 | 1 | 1 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.164665e-01 | 0.145 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.193104e-01 | 0.143 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.241453e-01 | 0.140 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.241453e-01 | 0.140 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.241453e-01 | 0.140 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.260221e-01 | 0.139 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.261359e-01 | 0.139 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.261359e-01 | 0.139 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.279908e-01 | 0.138 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.279908e-01 | 0.138 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.279908e-01 | 0.138 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.303249e-01 | 0.136 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.374875e-01 | 0.132 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.374875e-01 | 0.132 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.374875e-01 | 0.132 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.374875e-01 | 0.132 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.374875e-01 | 0.132 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.375680e-01 | 0.132 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.413227e-01 | 0.130 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.425949e-01 | 0.129 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.468560e-01 | 0.127 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.468560e-01 | 0.127 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.501851e-01 | 0.125 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.501851e-01 | 0.125 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.501851e-01 | 0.125 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.501851e-01 | 0.125 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.501851e-01 | 0.125 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.501851e-01 | 0.125 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.559729e-01 | 0.121 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.584221e-01 | 0.120 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.620953e-01 | 0.118 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.622693e-01 | 0.118 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.622693e-01 | 0.118 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.622693e-01 | 0.118 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.622693e-01 | 0.118 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.622693e-01 | 0.118 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.622693e-01 | 0.118 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 7.622693e-01 | 0.118 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.622693e-01 | 0.118 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.622693e-01 | 0.118 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.645866e-01 | 0.117 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.662839e-01 | 0.116 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.670953e-01 | 0.115 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.687628e-01 | 0.114 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.710907e-01 | 0.113 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.720183e-01 | 0.112 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.737669e-01 | 0.111 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.737696e-01 | 0.111 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.737696e-01 | 0.111 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.737696e-01 | 0.111 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.737696e-01 | 0.111 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.741069e-01 | 0.111 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.760379e-01 | 0.110 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.811086e-01 | 0.107 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.812288e-01 | 0.107 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.847143e-01 | 0.105 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.847143e-01 | 0.105 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.847143e-01 | 0.105 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 7.847143e-01 | 0.105 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.847143e-01 | 0.105 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.847143e-01 | 0.105 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.847143e-01 | 0.105 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.914526e-01 | 0.102 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.928845e-01 | 0.101 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.951301e-01 | 0.100 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.951301e-01 | 0.100 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.951301e-01 | 0.100 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.951301e-01 | 0.100 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.951301e-01 | 0.100 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.951301e-01 | 0.100 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.951301e-01 | 0.100 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 7.951301e-01 | 0.100 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.968299e-01 | 0.099 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.968299e-01 | 0.099 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.005338e-01 | 0.097 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.042422e-01 | 0.095 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.042550e-01 | 0.095 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.042550e-01 | 0.095 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.050426e-01 | 0.094 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.050426e-01 | 0.094 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.050426e-01 | 0.094 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.050426e-01 | 0.094 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.050426e-01 | 0.094 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.050426e-01 | 0.094 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.050426e-01 | 0.094 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.050426e-01 | 0.094 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.050426e-01 | 0.094 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.050426e-01 | 0.094 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.114670e-01 | 0.091 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.121352e-01 | 0.090 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.144760e-01 | 0.089 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.144760e-01 | 0.089 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.144760e-01 | 0.089 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.144760e-01 | 0.089 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.144760e-01 | 0.089 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.144760e-01 | 0.089 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 8.144760e-01 | 0.089 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.144760e-01 | 0.089 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.183848e-01 | 0.087 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.216468e-01 | 0.085 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.216468e-01 | 0.085 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.216468e-01 | 0.085 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.234535e-01 | 0.084 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.234535e-01 | 0.084 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.234535e-01 | 0.084 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.234535e-01 | 0.084 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.234535e-01 | 0.084 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.251015e-01 | 0.083 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.252117e-01 | 0.083 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.276605e-01 | 0.082 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.315940e-01 | 0.080 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.319972e-01 | 0.080 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.319972e-01 | 0.080 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.319972e-01 | 0.080 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.319972e-01 | 0.080 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.319972e-01 | 0.080 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.319972e-01 | 0.080 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.319972e-01 | 0.080 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.319972e-01 | 0.080 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.401278e-01 | 0.076 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.401278e-01 | 0.076 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.421829e-01 | 0.075 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.439304e-01 | 0.074 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.439304e-01 | 0.074 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.478655e-01 | 0.072 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.519109e-01 | 0.070 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.552291e-01 | 0.068 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.552291e-01 | 0.068 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.552291e-01 | 0.068 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 8.552291e-01 | 0.068 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.552291e-01 | 0.068 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.552291e-01 | 0.068 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.552291e-01 | 0.068 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.552291e-01 | 0.068 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.554409e-01 | 0.068 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.583474e-01 | 0.066 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.609009e-01 | 0.065 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.622367e-01 | 0.064 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.622367e-01 | 0.064 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.622367e-01 | 0.064 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.622367e-01 | 0.064 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.622367e-01 | 0.064 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.664901e-01 | 0.062 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.689055e-01 | 0.061 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 8.689055e-01 | 0.061 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.712582e-01 | 0.060 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.752519e-01 | 0.058 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.752519e-01 | 0.058 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.761665e-01 | 0.057 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.812914e-01 | 0.055 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.812914e-01 | 0.055 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.812914e-01 | 0.055 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.812914e-01 | 0.055 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.812914e-01 | 0.055 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.812914e-01 | 0.055 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.861412e-01 | 0.052 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 8.870389e-01 | 0.052 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.870389e-01 | 0.052 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.870389e-01 | 0.052 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.870389e-01 | 0.052 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.870389e-01 | 0.052 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.880073e-01 | 0.052 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.925084e-01 | 0.049 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.977134e-01 | 0.047 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.977134e-01 | 0.047 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.977134e-01 | 0.047 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.021621e-01 | 0.045 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.026635e-01 | 0.044 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.026667e-01 | 0.044 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.026667e-01 | 0.044 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.026667e-01 | 0.044 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.026667e-01 | 0.044 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.026667e-01 | 0.044 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.026667e-01 | 0.044 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.026667e-01 | 0.044 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.026667e-01 | 0.044 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.026667e-01 | 0.044 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.027412e-01 | 0.044 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.073804e-01 | 0.042 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.073804e-01 | 0.042 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.096303e-01 | 0.041 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.096303e-01 | 0.041 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.118661e-01 | 0.040 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.118661e-01 | 0.040 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.118661e-01 | 0.040 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.118661e-01 | 0.040 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.118661e-01 | 0.040 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.131610e-01 | 0.039 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.131610e-01 | 0.039 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.150058e-01 | 0.039 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.161348e-01 | 0.038 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.161348e-01 | 0.038 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.161348e-01 | 0.038 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.165620e-01 | 0.038 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.198376e-01 | 0.036 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.201970e-01 | 0.036 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.221379e-01 | 0.035 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.240626e-01 | 0.034 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.240626e-01 | 0.034 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.240626e-01 | 0.034 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.240626e-01 | 0.034 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.260290e-01 | 0.033 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.260290e-01 | 0.033 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.261547e-01 | 0.033 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.261547e-01 | 0.033 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.277413e-01 | 0.033 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.277413e-01 | 0.033 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.289528e-01 | 0.032 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.294042e-01 | 0.032 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.312419e-01 | 0.031 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.312419e-01 | 0.031 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.317672e-01 | 0.031 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.323851e-01 | 0.030 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.335108e-01 | 0.030 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.361397e-01 | 0.029 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.377432e-01 | 0.028 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.377432e-01 | 0.028 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.390234e-01 | 0.027 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.403817e-01 | 0.027 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.436305e-01 | 0.025 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.444244e-01 | 0.025 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.462523e-01 | 0.024 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.463622e-01 | 0.024 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.463622e-01 | 0.024 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.489617e-01 | 0.023 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.514354e-01 | 0.022 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.560292e-01 | 0.020 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.560292e-01 | 0.020 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.564985e-01 | 0.019 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.567446e-01 | 0.019 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.570287e-01 | 0.019 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.582621e-01 | 0.019 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.601890e-01 | 0.018 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.601890e-01 | 0.018 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.601890e-01 | 0.018 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.621191e-01 | 0.017 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.621191e-01 | 0.017 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.639558e-01 | 0.016 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.646553e-01 | 0.016 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.657034e-01 | 0.015 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.657034e-01 | 0.015 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.657034e-01 | 0.015 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.658969e-01 | 0.015 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.673665e-01 | 0.014 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.673665e-01 | 0.014 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.673665e-01 | 0.014 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.689490e-01 | 0.014 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.689490e-01 | 0.014 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.689490e-01 | 0.014 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.717452e-01 | 0.012 | 1 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.725122e-01 | 0.012 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.736557e-01 | 0.012 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.740710e-01 | 0.011 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.757833e-01 | 0.011 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.757833e-01 | 0.011 | 0 | 0 |
| Translation | R-HSA-72766 | 9.769339e-01 | 0.010 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.769581e-01 | 0.010 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.769581e-01 | 0.010 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.777461e-01 | 0.010 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.791396e-01 | 0.009 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.801517e-01 | 0.009 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.801517e-01 | 0.009 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.801517e-01 | 0.009 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.801517e-01 | 0.009 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.811148e-01 | 0.008 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.811148e-01 | 0.008 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.830323e-01 | 0.007 | 1 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.843527e-01 | 0.007 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.848388e-01 | 0.007 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.854756e-01 | 0.006 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.859886e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.859886e-01 | 0.006 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.866687e-01 | 0.006 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.871321e-01 | 0.006 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.895334e-01 | 0.005 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.920744e-01 | 0.003 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.926644e-01 | 0.003 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.926743e-01 | 0.003 | 1 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.939895e-01 | 0.003 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.939895e-01 | 0.003 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.946548e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.949570e-01 | 0.002 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.950031e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.950754e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.950754e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.955425e-01 | 0.002 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.955425e-01 | 0.002 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.958965e-01 | 0.002 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.965257e-01 | 0.002 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.972464e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.975493e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.976953e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.983557e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.990966e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.991246e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.991805e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.992223e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.993305e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.995460e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.995495e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.995511e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.995549e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.996296e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.996451e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.997256e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.997656e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.997880e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.997915e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998098e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998106e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.998155e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.998349e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.998496e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999091e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999295e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999295e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999451e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999639e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999658e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999835e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999843e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999991e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999997e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999997e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.000000e+00 | 0.000 | 1 | 1 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.000000e+00 | 0.000 | 1 | 1 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.000000e+00 | 0.000 | 1 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 1.110223e-15 | 14.955 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.662937e-15 | 14.331 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.995204e-15 | 14.222 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.010303e-14 | 13.996 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.421085e-14 | 13.847 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.609823e-14 | 13.793 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.274359e-14 | 13.369 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.659740e-14 | 13.062 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.544276e-13 | 12.068 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.144685e-12 | 11.383 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.416578e-12 | 11.355 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.019473e-11 | 10.695 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.831136e-11 | 10.166 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.212552e-10 | 9.493 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.407764e-10 | 9.468 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.864851e-10 | 9.413 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.127535e-10 | 9.290 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.351969e-09 | 8.869 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.203802e-09 | 8.376 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.217213e-09 | 8.142 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.509399e-09 | 8.070 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.018587e-08 | 7.992 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.139329e-08 | 7.943 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.412579e-08 | 7.850 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.663839e-08 | 7.779 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.318784e-08 | 7.635 | 1 | 0 |
| Cell junction organization | R-HSA-446728 | 2.428946e-08 | 7.615 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.518835e-08 | 7.599 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.353301e-08 | 7.475 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.561136e-08 | 7.448 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.790085e-08 | 7.421 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.736496e-08 | 7.428 | 1 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.834468e-08 | 7.316 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.900410e-08 | 7.051 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.096405e-07 | 6.960 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.449112e-07 | 6.839 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.449112e-07 | 6.839 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.525386e-07 | 6.817 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.525386e-07 | 6.817 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.118950e-07 | 6.674 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.292752e-07 | 6.640 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.440469e-07 | 6.613 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.571267e-07 | 6.447 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.185603e-07 | 6.378 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.567788e-07 | 6.340 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.803560e-07 | 6.318 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.803560e-07 | 6.318 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.803560e-07 | 6.318 | 1 | 1 |
| mRNA Splicing | R-HSA-72172 | 4.794076e-07 | 6.319 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.803560e-07 | 6.318 | 1 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.335264e-07 | 6.273 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.393064e-07 | 6.268 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.544090e-07 | 6.256 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.981397e-07 | 6.223 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.653792e-07 | 6.177 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 7.538061e-07 | 6.123 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.075840e-06 | 5.968 | 1 | 1 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.129640e-06 | 5.947 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.298512e-06 | 5.887 | 1 | 1 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.454791e-06 | 5.837 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.521169e-06 | 5.818 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.779422e-06 | 5.750 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.177915e-06 | 5.662 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.158068e-06 | 5.501 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.728295e-06 | 5.428 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.959944e-06 | 5.402 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.640931e-06 | 5.333 | 1 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.934328e-06 | 5.307 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.000080e-06 | 5.301 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.163730e-06 | 5.287 | 1 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.504627e-06 | 5.259 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.556164e-06 | 5.255 | 1 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.103549e-06 | 5.214 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.209785e-06 | 5.207 | 1 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.132150e-06 | 5.147 | 1 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.132150e-06 | 5.147 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.304315e-06 | 5.081 | 1 | 1 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 8.594764e-06 | 5.066 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.631218e-06 | 5.016 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.094676e-05 | 4.961 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.126164e-05 | 4.948 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.187176e-05 | 4.925 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.418564e-05 | 4.848 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.595964e-05 | 4.797 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.609424e-05 | 4.793 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.810738e-05 | 4.742 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.017680e-05 | 4.695 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.017680e-05 | 4.695 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.076163e-05 | 4.683 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.282888e-05 | 4.642 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.264647e-05 | 4.645 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.336167e-05 | 4.631 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.375289e-05 | 4.624 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.388135e-05 | 4.622 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.649915e-05 | 4.577 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.211055e-05 | 4.493 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.707848e-05 | 4.431 | 1 | 1 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.657308e-05 | 4.437 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.783573e-05 | 4.422 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.826795e-05 | 4.417 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.726059e-05 | 4.326 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.726059e-05 | 4.326 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.871642e-05 | 4.312 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.871642e-05 | 4.312 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.955967e-05 | 4.225 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.977635e-05 | 4.223 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.046220e-05 | 4.219 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.479302e-05 | 4.188 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.479302e-05 | 4.188 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.693502e-05 | 4.174 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.292789e-05 | 4.137 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.830307e-05 | 4.166 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.358534e-05 | 4.133 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.839260e-05 | 4.106 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.950179e-05 | 4.100 | 1 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.494891e-05 | 4.071 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.511987e-05 | 4.070 | 1 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.563997e-05 | 4.067 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.599818e-05 | 4.066 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.642332e-05 | 4.063 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.948461e-05 | 4.048 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.038678e-05 | 4.044 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.324477e-05 | 4.030 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.877930e-05 | 4.005 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.971039e-05 | 4.001 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.971039e-05 | 4.001 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.036563e-04 | 3.984 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.055120e-04 | 3.977 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.055120e-04 | 3.977 | 1 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.101486e-04 | 3.958 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.101486e-04 | 3.958 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.148839e-04 | 3.940 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.216987e-04 | 3.915 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.212604e-04 | 3.916 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.212604e-04 | 3.916 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.286733e-04 | 3.891 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.302327e-04 | 3.885 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.345080e-04 | 3.871 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.370024e-04 | 3.863 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.452827e-04 | 3.838 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.458136e-04 | 3.836 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.468564e-04 | 3.833 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.475898e-04 | 3.831 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.644181e-04 | 3.784 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.703542e-04 | 3.769 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.808320e-04 | 3.743 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.808320e-04 | 3.743 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.908482e-04 | 3.719 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.908482e-04 | 3.719 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.976261e-04 | 3.704 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.976261e-04 | 3.704 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.976261e-04 | 3.704 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.004666e-04 | 3.698 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.093495e-04 | 3.679 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.094070e-04 | 3.679 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.103603e-04 | 3.677 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.155297e-04 | 3.666 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.200863e-04 | 3.657 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.453317e-04 | 3.610 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.453317e-04 | 3.610 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.462506e-04 | 3.609 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.372647e-04 | 3.625 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.372647e-04 | 3.625 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.462506e-04 | 3.609 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.237866e-04 | 3.650 | 1 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.502624e-04 | 3.602 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.503387e-04 | 3.601 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.565470e-04 | 3.591 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.641554e-04 | 3.578 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.737708e-04 | 3.563 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.737708e-04 | 3.563 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.782537e-04 | 3.556 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.804378e-04 | 3.552 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.848393e-04 | 3.545 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.904125e-04 | 3.537 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.904125e-04 | 3.537 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.028602e-04 | 3.519 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.028602e-04 | 3.519 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.115936e-04 | 3.506 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.115936e-04 | 3.506 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.227136e-04 | 3.491 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.315862e-04 | 3.479 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.528739e-04 | 3.452 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.790438e-04 | 3.421 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.526169e-04 | 3.453 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.446483e-04 | 3.463 | 1 | 1 |
| PCP/CE pathway | R-HSA-4086400 | 3.564997e-04 | 3.448 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.446483e-04 | 3.463 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.215988e-04 | 3.375 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.369850e-04 | 3.360 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.369850e-04 | 3.360 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.454531e-04 | 3.351 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.454531e-04 | 3.351 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.454531e-04 | 3.351 | 1 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.612031e-04 | 3.336 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.612031e-04 | 3.336 | 1 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.761093e-04 | 3.322 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.820025e-04 | 3.317 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.914450e-04 | 3.309 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.055209e-04 | 3.296 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.215314e-04 | 3.283 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.597574e-04 | 3.252 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.968099e-04 | 3.224 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.968099e-04 | 3.224 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.055562e-04 | 3.218 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.844523e-04 | 3.233 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.069960e-04 | 3.217 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.069960e-04 | 3.217 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.069960e-04 | 3.217 | 1 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.202138e-04 | 3.207 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.361926e-04 | 3.196 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.538125e-04 | 3.185 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.878244e-04 | 3.163 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.994195e-04 | 3.155 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.166400e-04 | 3.145 | 1 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.862270e-04 | 3.104 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.039584e-04 | 3.095 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.097302e-04 | 3.092 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.240347e-04 | 3.084 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.524375e-04 | 3.069 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.771393e-04 | 3.057 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.076117e-04 | 3.042 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.364209e-04 | 3.029 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.388475e-04 | 3.027 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.445940e-04 | 3.025 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.707245e-04 | 3.013 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.841585e-04 | 3.007 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.841585e-04 | 3.007 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.090751e-03 | 2.962 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.091988e-03 | 2.962 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.091988e-03 | 2.962 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.097700e-03 | 2.960 | 1 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.107986e-03 | 2.955 | 1 | 1 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.108586e-03 | 2.955 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.129432e-03 | 2.947 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.129432e-03 | 2.947 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.141067e-03 | 2.943 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.141067e-03 | 2.943 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.339448e-03 | 2.873 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.339448e-03 | 2.873 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.268086e-03 | 2.897 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.268086e-03 | 2.897 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.242884e-03 | 2.906 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.242884e-03 | 2.906 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.398869e-03 | 2.854 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.405137e-03 | 2.852 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.415673e-03 | 2.849 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.415673e-03 | 2.849 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.415673e-03 | 2.849 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.433070e-03 | 2.844 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.433070e-03 | 2.844 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.467749e-03 | 2.833 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.467749e-03 | 2.833 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.475324e-03 | 2.831 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.475531e-03 | 2.831 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.475531e-03 | 2.831 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.535563e-03 | 2.814 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.556518e-03 | 2.808 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.556518e-03 | 2.808 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.610608e-03 | 2.793 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.683366e-03 | 2.774 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.693926e-03 | 2.771 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.714853e-03 | 2.766 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.716888e-03 | 2.765 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.743882e-03 | 2.758 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.831845e-03 | 2.737 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.831845e-03 | 2.737 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.954481e-03 | 2.709 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.933778e-03 | 2.714 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.898696e-03 | 2.722 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.898696e-03 | 2.722 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.022093e-03 | 2.694 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.184149e-03 | 2.661 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.917828e-03 | 2.717 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.917828e-03 | 2.717 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.252576e-03 | 2.647 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.250304e-03 | 2.648 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.933778e-03 | 2.714 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.933778e-03 | 2.714 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.183603e-03 | 2.661 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.898696e-03 | 2.722 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.126048e-03 | 2.672 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.256489e-03 | 2.647 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.294055e-03 | 2.639 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.311343e-03 | 2.636 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.311343e-03 | 2.636 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.323089e-03 | 2.634 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.384228e-03 | 2.623 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.475211e-03 | 2.606 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.475211e-03 | 2.606 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.542431e-03 | 2.595 | 1 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.569227e-03 | 2.590 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.604400e-03 | 2.584 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.611575e-03 | 2.583 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.617409e-03 | 2.582 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.645512e-03 | 2.577 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.645512e-03 | 2.577 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.714870e-03 | 2.566 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.714870e-03 | 2.566 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.714870e-03 | 2.566 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.714870e-03 | 2.566 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.714870e-03 | 2.566 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.714870e-03 | 2.566 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.714870e-03 | 2.566 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.714870e-03 | 2.566 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.714870e-03 | 2.566 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.714870e-03 | 2.566 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.714870e-03 | 2.566 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.858803e-03 | 2.544 | 1 | 0 |
| Pexophagy | R-HSA-9664873 | 2.860379e-03 | 2.544 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.860379e-03 | 2.544 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.860379e-03 | 2.544 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.908342e-03 | 2.536 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.908342e-03 | 2.536 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.918274e-03 | 2.535 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.918274e-03 | 2.535 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.132288e-03 | 2.504 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.132288e-03 | 2.504 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.341531e-03 | 2.476 | 1 | 1 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.625495e-03 | 2.441 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.405189e-03 | 2.468 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.066113e-03 | 2.391 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.066113e-03 | 2.391 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.016556e-03 | 2.396 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.016556e-03 | 2.396 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.367161e-03 | 2.473 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.511266e-03 | 2.455 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.760592e-03 | 2.425 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.511266e-03 | 2.455 | 1 | 1 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.985320e-03 | 2.400 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.526511e-03 | 2.453 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.497892e-03 | 2.456 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.302473e-03 | 2.481 | 1 | 0 |
| HIV Infection | R-HSA-162906 | 3.798459e-03 | 2.420 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.302473e-03 | 2.481 | 1 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.265040e-03 | 2.486 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.494274e-03 | 2.457 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.292588e-03 | 2.482 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.998351e-03 | 2.398 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.547161e-03 | 2.450 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.447229e-03 | 2.463 | 1 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.367161e-03 | 2.473 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.760592e-03 | 2.425 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.227845e-03 | 2.374 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.263562e-03 | 2.370 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.282951e-03 | 2.368 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.282951e-03 | 2.368 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.320612e-03 | 2.364 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.456411e-03 | 2.351 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.479664e-03 | 2.349 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.479664e-03 | 2.349 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.479664e-03 | 2.349 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.481399e-03 | 2.349 | 1 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.488834e-03 | 2.348 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.522651e-03 | 2.345 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.540657e-03 | 2.343 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.540657e-03 | 2.343 | 1 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.726537e-03 | 2.325 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.761723e-03 | 2.322 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.860114e-03 | 2.313 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.860114e-03 | 2.313 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.978468e-03 | 2.303 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 4.978468e-03 | 2.303 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.138487e-03 | 2.289 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 5.260727e-03 | 2.279 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.260727e-03 | 2.279 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.260727e-03 | 2.279 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.260727e-03 | 2.279 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.328325e-03 | 2.273 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.443019e-03 | 2.264 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.471876e-03 | 2.262 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.471876e-03 | 2.262 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.478309e-03 | 2.261 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.488820e-03 | 2.261 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.488820e-03 | 2.261 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.494937e-03 | 2.260 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.696874e-03 | 2.244 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.767842e-03 | 2.239 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.834609e-03 | 2.234 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.934724e-03 | 2.227 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.935447e-03 | 2.227 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.977473e-03 | 2.223 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.069084e-03 | 2.217 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.133522e-03 | 2.212 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.153019e-03 | 2.211 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.260360e-03 | 2.203 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.371330e-03 | 2.196 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.386077e-03 | 2.195 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.386077e-03 | 2.195 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.671951e-03 | 2.176 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.671951e-03 | 2.176 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.852328e-03 | 2.164 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.929376e-03 | 2.159 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.104101e-03 | 2.148 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.263795e-03 | 2.139 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.428385e-03 | 2.129 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.478046e-03 | 2.126 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.594135e-03 | 2.120 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.888658e-03 | 2.103 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.888658e-03 | 2.103 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.981056e-03 | 2.098 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.048933e-03 | 2.094 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.127339e-03 | 2.090 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.375760e-03 | 2.077 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.490999e-03 | 2.071 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.490999e-03 | 2.071 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.511666e-03 | 2.070 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 8.532049e-03 | 2.069 | 1 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.551609e-03 | 2.068 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.555538e-03 | 2.068 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.562697e-03 | 2.067 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.179804e-03 | 2.037 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.640395e-03 | 2.016 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 9.759663e-03 | 2.011 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.800587e-03 | 2.009 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.914687e-03 | 2.004 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.914687e-03 | 2.004 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.102808e-02 | 1.958 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.102808e-02 | 1.958 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.102808e-02 | 1.958 | 1 | 1 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.174036e-02 | 1.930 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.041786e-02 | 1.982 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.130926e-02 | 1.947 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.077377e-02 | 1.968 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.325996e-02 | 1.877 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.041786e-02 | 1.982 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.266349e-02 | 1.897 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.134937e-02 | 1.945 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.003945e-02 | 1.998 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.117637e-02 | 1.952 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.106831e-02 | 1.956 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.082860e-02 | 1.965 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.008998e-02 | 1.996 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.106831e-02 | 1.956 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.058749e-02 | 1.975 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.313216e-02 | 1.882 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.425722e-02 | 1.846 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.438099e-02 | 1.842 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.438099e-02 | 1.842 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.525873e-02 | 1.816 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.529872e-02 | 1.815 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.538705e-02 | 1.813 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.539660e-02 | 1.813 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.539660e-02 | 1.813 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.539660e-02 | 1.813 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.572936e-02 | 1.803 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.576339e-02 | 1.802 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.629229e-02 | 1.788 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.629229e-02 | 1.788 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.720161e-02 | 1.764 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.820628e-02 | 1.740 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.823428e-02 | 1.739 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.823428e-02 | 1.739 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.837580e-02 | 1.736 | 1 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.858055e-02 | 1.731 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.858055e-02 | 1.731 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.902089e-02 | 1.721 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.902089e-02 | 1.721 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.902089e-02 | 1.721 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.902431e-02 | 1.721 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.981552e-02 | 1.703 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.997894e-02 | 1.699 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.997894e-02 | 1.699 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.997894e-02 | 1.699 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.109813e-02 | 1.676 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.109813e-02 | 1.676 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.118597e-02 | 1.674 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.122825e-02 | 1.673 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.124107e-02 | 1.673 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.124107e-02 | 1.673 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.124107e-02 | 1.673 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.124107e-02 | 1.673 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.124107e-02 | 1.673 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.156815e-02 | 1.666 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.174026e-02 | 1.663 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.180929e-02 | 1.661 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.270174e-02 | 1.644 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.270977e-02 | 1.644 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.334479e-02 | 1.632 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.353896e-02 | 1.628 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.357837e-02 | 1.627 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.357837e-02 | 1.627 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.419413e-02 | 1.616 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.428700e-02 | 1.615 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.489986e-02 | 1.604 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.531489e-02 | 1.597 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.543557e-02 | 1.595 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.543557e-02 | 1.595 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.543557e-02 | 1.595 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.543557e-02 | 1.595 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.544630e-02 | 1.594 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.575563e-02 | 1.589 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.618121e-02 | 1.582 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.699159e-02 | 1.569 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.728928e-02 | 1.564 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.787905e-02 | 1.555 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.787905e-02 | 1.555 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.787905e-02 | 1.555 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.787905e-02 | 1.555 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.787905e-02 | 1.555 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.794493e-02 | 1.554 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.794493e-02 | 1.554 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.803455e-02 | 1.552 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.803455e-02 | 1.552 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.803455e-02 | 1.552 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.803455e-02 | 1.552 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.859640e-02 | 1.544 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.892696e-02 | 1.539 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.892696e-02 | 1.539 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.917915e-02 | 1.535 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.927568e-02 | 1.533 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.927568e-02 | 1.533 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.930115e-02 | 1.533 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.931205e-02 | 1.533 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.931205e-02 | 1.533 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.931205e-02 | 1.533 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.974013e-02 | 1.527 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.315646e-02 | 1.479 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 3.315646e-02 | 1.479 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.315646e-02 | 1.479 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.315646e-02 | 1.479 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.315646e-02 | 1.479 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.315646e-02 | 1.479 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 4.031188e-02 | 1.395 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.910831e-02 | 1.408 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.910831e-02 | 1.408 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.575744e-02 | 1.447 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.575744e-02 | 1.447 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.183159e-02 | 1.497 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.493786e-02 | 1.347 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.922246e-02 | 1.406 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.396008e-02 | 1.469 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.079739e-02 | 1.389 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.116397e-02 | 1.385 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.497241e-02 | 1.456 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.497241e-02 | 1.456 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.075113e-02 | 1.390 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.394973e-02 | 1.357 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.110843e-02 | 1.386 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.964411e-02 | 1.402 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.615017e-02 | 1.442 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.148274e-02 | 1.502 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.561185e-02 | 1.448 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.189443e-02 | 1.378 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.264021e-02 | 1.370 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.575744e-02 | 1.447 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.079739e-02 | 1.389 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.348121e-02 | 1.362 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.075113e-02 | 1.390 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.127760e-02 | 1.384 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.079739e-02 | 1.389 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.551707e-02 | 1.450 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.075113e-02 | 1.390 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.910831e-02 | 1.408 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.396008e-02 | 1.469 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.452827e-02 | 1.462 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.561185e-02 | 1.448 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.189443e-02 | 1.378 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.963602e-02 | 1.402 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.264021e-02 | 1.370 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.575744e-02 | 1.447 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.183159e-02 | 1.497 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.394973e-02 | 1.357 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.191122e-02 | 1.496 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.910831e-02 | 1.408 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.394973e-02 | 1.357 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.031188e-02 | 1.395 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.493786e-02 | 1.347 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.394973e-02 | 1.357 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.396008e-02 | 1.469 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.206844e-02 | 1.376 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.428289e-02 | 1.465 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.483735e-02 | 1.458 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.372177e-02 | 1.472 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.115111e-02 | 1.507 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.478545e-02 | 1.349 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.706563e-02 | 1.431 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.452827e-02 | 1.462 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.493786e-02 | 1.347 | 1 | 1 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.242847e-02 | 1.489 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.501202e-02 | 1.347 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.501202e-02 | 1.347 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.659951e-02 | 1.332 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.715150e-02 | 1.327 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.715150e-02 | 1.327 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.741183e-02 | 1.324 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.765275e-02 | 1.322 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.765275e-02 | 1.322 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.765275e-02 | 1.322 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.765275e-02 | 1.322 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.765275e-02 | 1.322 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.765275e-02 | 1.322 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.812399e-02 | 1.318 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.817926e-02 | 1.317 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.817926e-02 | 1.317 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.849215e-02 | 1.314 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.939520e-02 | 1.306 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.979444e-02 | 1.303 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.067955e-02 | 1.295 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.067955e-02 | 1.295 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.067955e-02 | 1.295 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.067955e-02 | 1.295 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.067955e-02 | 1.295 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.067955e-02 | 1.295 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.103088e-02 | 1.292 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.129979e-02 | 1.290 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.209085e-02 | 1.283 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.231501e-02 | 1.281 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.419514e-02 | 1.266 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.419514e-02 | 1.266 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.454356e-02 | 1.263 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.454356e-02 | 1.263 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.454356e-02 | 1.263 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.454356e-02 | 1.263 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.454356e-02 | 1.263 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.505497e-02 | 1.259 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.519173e-02 | 1.258 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.519173e-02 | 1.258 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.519173e-02 | 1.258 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.519173e-02 | 1.258 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.546222e-02 | 1.256 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.546222e-02 | 1.256 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.546222e-02 | 1.256 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.546222e-02 | 1.256 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.614782e-02 | 1.251 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.614782e-02 | 1.251 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.626987e-02 | 1.250 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.707206e-02 | 1.244 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.715533e-02 | 1.243 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.730960e-02 | 1.242 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.965876e-02 | 1.224 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.217111e-02 | 1.206 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.302315e-02 | 1.200 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.302315e-02 | 1.200 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.405046e-02 | 1.193 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.405046e-02 | 1.193 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.405046e-02 | 1.193 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.405046e-02 | 1.193 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.447290e-02 | 1.191 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.447290e-02 | 1.191 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.655679e-02 | 1.177 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.655679e-02 | 1.177 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.735220e-02 | 1.172 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.735220e-02 | 1.172 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.735220e-02 | 1.172 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.775078e-02 | 1.169 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.775078e-02 | 1.169 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 6.809115e-02 | 1.167 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.809115e-02 | 1.167 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.858077e-02 | 1.164 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.875112e-02 | 1.163 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.043124e-02 | 1.152 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.043124e-02 | 1.152 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.051602e-02 | 1.152 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.077461e-02 | 1.150 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.236129e-02 | 1.140 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.263459e-02 | 1.139 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.263459e-02 | 1.139 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.263459e-02 | 1.139 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.263459e-02 | 1.139 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 7.263459e-02 | 1.139 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.335319e-02 | 1.135 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.378284e-02 | 1.132 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.557735e-02 | 1.122 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.590025e-02 | 1.120 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.695770e-02 | 1.114 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 7.831853e-02 | 1.106 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 7.831853e-02 | 1.106 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 7.831853e-02 | 1.106 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 7.831853e-02 | 1.106 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.838026e-02 | 1.106 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.920952e-02 | 1.101 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.920952e-02 | 1.101 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.920952e-02 | 1.101 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.920952e-02 | 1.101 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.920952e-02 | 1.101 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.920952e-02 | 1.101 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.920952e-02 | 1.101 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.060945e-02 | 1.094 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.060945e-02 | 1.094 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.060945e-02 | 1.094 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.073921e-02 | 1.093 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.145176e-02 | 1.089 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.145176e-02 | 1.089 | 1 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.153457e-02 | 1.089 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.387940e-02 | 1.076 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.387940e-02 | 1.076 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.515587e-02 | 1.070 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.680647e-02 | 1.061 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.731830e-02 | 1.059 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.827771e-02 | 1.054 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 8.827771e-02 | 1.054 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.838658e-02 | 1.054 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.934435e-02 | 1.049 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.934435e-02 | 1.049 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.081269e-02 | 1.042 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.224040e-02 | 1.035 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.224040e-02 | 1.035 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.224040e-02 | 1.035 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.224040e-02 | 1.035 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.249701e-02 | 1.034 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 9.253165e-02 | 1.034 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 9.253165e-02 | 1.034 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 9.253165e-02 | 1.034 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.339898e-02 | 1.030 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.427649e-02 | 1.026 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.521624e-02 | 1.021 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 9.521624e-02 | 1.021 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.521624e-02 | 1.021 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.570432e-02 | 1.019 | 1 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.592017e-02 | 1.018 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 9.611180e-02 | 1.017 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 9.611180e-02 | 1.017 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 9.611180e-02 | 1.017 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.953074e-02 | 1.002 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.005114e-01 | 0.998 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.005114e-01 | 0.998 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.009947e-01 | 0.996 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.318098e-01 | 0.880 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.318098e-01 | 0.880 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.318098e-01 | 0.880 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.318098e-01 | 0.880 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.318098e-01 | 0.880 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.318098e-01 | 0.880 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.318098e-01 | 0.880 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.318098e-01 | 0.880 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.318098e-01 | 0.880 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.318098e-01 | 0.880 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.318098e-01 | 0.880 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.318098e-01 | 0.880 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.318098e-01 | 0.880 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.318098e-01 | 0.880 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.318098e-01 | 0.880 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.318098e-01 | 0.880 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.318098e-01 | 0.880 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.318098e-01 | 0.880 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.318098e-01 | 0.880 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.318098e-01 | 0.880 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.318098e-01 | 0.880 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.318098e-01 | 0.880 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.318098e-01 | 0.880 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.318098e-01 | 0.880 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.318098e-01 | 0.880 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.318098e-01 | 0.880 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.318098e-01 | 0.880 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.106148e-01 | 0.956 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 1.106148e-01 | 0.956 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.106148e-01 | 0.956 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 1.106148e-01 | 0.956 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.106148e-01 | 0.956 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 1.581216e-01 | 0.801 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.581216e-01 | 0.801 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.581216e-01 | 0.801 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.581216e-01 | 0.801 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.058027e-01 | 0.976 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 1.364565e-01 | 0.865 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.364565e-01 | 0.865 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.364565e-01 | 0.865 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.147180e-01 | 0.940 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.147180e-01 | 0.940 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.697058e-01 | 0.770 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.697058e-01 | 0.770 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.697058e-01 | 0.770 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.697058e-01 | 0.770 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.697058e-01 | 0.770 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.697058e-01 | 0.770 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.389853e-01 | 0.857 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.146826e-01 | 0.941 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.650947e-01 | 0.782 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.650947e-01 | 0.782 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.348216e-01 | 0.870 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.348216e-01 | 0.870 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.348216e-01 | 0.870 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.348216e-01 | 0.870 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.111367e-01 | 0.954 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.564071e-01 | 0.806 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.927869e-01 | 0.715 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.927869e-01 | 0.715 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.466933e-01 | 0.834 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.793005e-01 | 0.746 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.064297e-01 | 0.973 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.276569e-01 | 0.894 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.033507e-01 | 0.692 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.425182e-01 | 0.846 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.866927e-01 | 0.729 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.320584e-01 | 0.879 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.717027e-01 | 0.765 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.084010e-01 | 0.965 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.084010e-01 | 0.965 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.084010e-01 | 0.965 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.084010e-01 | 0.965 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.084010e-01 | 0.965 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.918077e-01 | 0.717 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.090729e-01 | 0.962 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.179317e-01 | 0.928 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.376288e-01 | 0.861 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.376288e-01 | 0.861 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.362207e-01 | 0.866 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.079824e-01 | 0.967 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.374326e-01 | 0.862 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.313504e-01 | 0.882 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.746387e-01 | 0.758 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.090859e-01 | 0.962 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.248375e-01 | 0.904 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.248375e-01 | 0.904 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.466933e-01 | 0.834 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.176951e-01 | 0.929 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.020060e-01 | 0.991 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.147180e-01 | 0.940 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.349084e-01 | 0.870 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.020060e-01 | 0.991 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.020060e-01 | 0.991 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.741944e-01 | 0.759 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.903629e-01 | 0.720 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.378231e-01 | 0.861 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.716168e-01 | 0.765 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.175123e-01 | 0.930 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.538871e-01 | 0.813 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.364565e-01 | 0.865 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.411190e-01 | 0.850 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.094278e-01 | 0.961 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.147180e-01 | 0.940 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.147180e-01 | 0.940 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.064297e-01 | 0.973 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.263319e-01 | 0.898 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.310286e-01 | 0.883 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.348216e-01 | 0.870 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.369807e-01 | 0.863 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.686986e-01 | 0.773 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.980612e-01 | 0.703 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.482551e-01 | 0.829 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.378231e-01 | 0.861 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.364565e-01 | 0.865 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.564071e-01 | 0.806 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 1.466933e-01 | 0.834 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.639914e-01 | 0.785 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.127748e-01 | 0.948 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.564071e-01 | 0.806 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.605872e-01 | 0.794 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.593090e-01 | 0.798 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.146826e-01 | 0.941 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.466933e-01 | 0.834 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.136449e-01 | 0.944 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.276569e-01 | 0.894 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.242357e-01 | 0.906 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.793005e-01 | 0.746 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.276569e-01 | 0.894 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.472171e-01 | 0.832 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 1.697058e-01 | 0.770 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.271475e-01 | 0.896 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.581216e-01 | 0.801 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.058027e-01 | 0.976 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.927869e-01 | 0.715 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.918402e-01 | 0.717 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.918077e-01 | 0.717 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.389853e-01 | 0.857 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.064297e-01 | 0.973 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.617087e-01 | 0.791 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.606084e-01 | 0.794 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.581216e-01 | 0.801 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.058027e-01 | 0.976 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.389853e-01 | 0.857 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.650947e-01 | 0.782 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.248375e-01 | 0.904 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.754191e-01 | 0.756 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.375078e-01 | 0.862 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.425182e-01 | 0.846 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.949149e-01 | 0.710 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.349084e-01 | 0.870 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.918077e-01 | 0.717 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.176951e-01 | 0.929 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.509954e-01 | 0.821 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.934370e-01 | 0.713 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.716168e-01 | 0.765 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.064297e-01 | 0.973 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.492724e-01 | 0.826 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.242357e-01 | 0.906 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.147180e-01 | 0.940 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.482551e-01 | 0.829 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.033507e-01 | 0.692 | 1 | 1 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.136250e-01 | 0.945 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.425182e-01 | 0.846 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 1.224503e-01 | 0.912 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.793005e-01 | 0.746 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.927869e-01 | 0.715 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.927869e-01 | 0.715 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.210402e-01 | 0.917 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.271475e-01 | 0.896 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.689434e-01 | 0.772 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.661819e-01 | 0.779 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.742334e-01 | 0.759 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.106532e-01 | 0.956 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.518590e-01 | 0.819 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.049756e-01 | 0.688 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.049756e-01 | 0.688 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.049756e-01 | 0.688 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 2.049756e-01 | 0.688 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.063605e-01 | 0.685 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.065041e-01 | 0.685 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.081262e-01 | 0.682 | 1 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.081262e-01 | 0.682 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.081262e-01 | 0.682 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.081262e-01 | 0.682 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.081262e-01 | 0.682 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.083676e-01 | 0.681 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.083676e-01 | 0.681 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 2.085604e-01 | 0.681 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.085604e-01 | 0.681 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.085604e-01 | 0.681 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.085604e-01 | 0.681 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.085604e-01 | 0.681 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.085604e-01 | 0.681 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.085604e-01 | 0.681 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.085604e-01 | 0.681 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.085604e-01 | 0.681 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.096472e-01 | 0.679 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.096472e-01 | 0.679 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.151744e-01 | 0.667 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.208948e-01 | 0.656 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.217928e-01 | 0.654 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.217928e-01 | 0.654 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.217928e-01 | 0.654 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.222819e-01 | 0.653 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.237863e-01 | 0.650 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.254448e-01 | 0.647 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.254448e-01 | 0.647 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.263966e-01 | 0.645 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.277396e-01 | 0.643 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.281002e-01 | 0.642 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.281002e-01 | 0.642 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.281002e-01 | 0.642 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.283983e-01 | 0.641 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.283983e-01 | 0.641 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.296958e-01 | 0.639 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.299288e-01 | 0.638 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.299288e-01 | 0.638 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.299288e-01 | 0.638 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.299288e-01 | 0.638 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.302588e-01 | 0.638 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.303759e-01 | 0.638 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.303759e-01 | 0.638 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.303759e-01 | 0.638 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.313357e-01 | 0.636 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.341666e-01 | 0.630 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.386658e-01 | 0.622 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 2.417128e-01 | 0.617 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.417128e-01 | 0.617 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.417128e-01 | 0.617 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.417128e-01 | 0.617 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 2.417128e-01 | 0.617 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.417128e-01 | 0.617 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.417128e-01 | 0.617 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.417128e-01 | 0.617 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.430250e-01 | 0.614 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.441673e-01 | 0.612 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.462525e-01 | 0.609 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.462525e-01 | 0.609 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 2.462525e-01 | 0.609 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 2.462525e-01 | 0.609 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.462525e-01 | 0.609 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.471064e-01 | 0.607 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.471064e-01 | 0.607 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.471064e-01 | 0.607 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.479499e-01 | 0.606 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.499232e-01 | 0.602 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.506785e-01 | 0.601 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.518408e-01 | 0.599 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.518408e-01 | 0.599 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.518408e-01 | 0.599 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.533311e-01 | 0.596 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.542789e-01 | 0.595 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.542789e-01 | 0.595 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.598785e-01 | 0.585 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.603338e-01 | 0.584 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.603338e-01 | 0.584 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.603338e-01 | 0.584 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.603338e-01 | 0.584 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.603338e-01 | 0.584 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.603338e-01 | 0.584 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.603338e-01 | 0.584 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 2.603338e-01 | 0.584 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.603338e-01 | 0.584 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.603338e-01 | 0.584 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.603338e-01 | 0.584 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 2.603338e-01 | 0.584 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.603338e-01 | 0.584 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.603338e-01 | 0.584 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.711269e-01 | 0.567 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.719632e-01 | 0.565 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.726604e-01 | 0.564 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.734418e-01 | 0.563 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.756437e-01 | 0.560 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.756437e-01 | 0.560 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.768780e-01 | 0.558 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.768780e-01 | 0.558 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.794016e-01 | 0.554 | 1 | 1 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.794016e-01 | 0.554 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 2.794016e-01 | 0.554 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.794016e-01 | 0.554 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.794016e-01 | 0.554 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.794016e-01 | 0.554 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.794945e-01 | 0.554 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.794945e-01 | 0.554 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.808268e-01 | 0.552 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.808268e-01 | 0.552 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.824886e-01 | 0.549 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.826645e-01 | 0.549 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.826645e-01 | 0.549 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.826645e-01 | 0.549 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 2.826645e-01 | 0.549 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.826645e-01 | 0.549 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.826645e-01 | 0.549 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.841506e-01 | 0.546 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.865773e-01 | 0.543 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.901869e-01 | 0.537 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.901869e-01 | 0.537 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.909410e-01 | 0.536 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.936984e-01 | 0.532 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.936984e-01 | 0.532 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.992256e-01 | 0.524 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.009023e-01 | 0.522 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.025598e-01 | 0.519 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.068050e-01 | 0.513 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 3.078781e-01 | 0.512 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.078781e-01 | 0.512 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.078781e-01 | 0.512 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.078781e-01 | 0.512 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.078781e-01 | 0.512 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.122142e-01 | 0.506 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.122142e-01 | 0.506 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.122142e-01 | 0.506 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.122142e-01 | 0.506 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.122142e-01 | 0.506 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.122142e-01 | 0.506 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.122142e-01 | 0.506 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.122142e-01 | 0.506 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.122142e-01 | 0.506 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.122142e-01 | 0.506 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.140071e-01 | 0.503 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.140071e-01 | 0.503 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 3.140071e-01 | 0.503 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.140071e-01 | 0.503 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 3.140071e-01 | 0.503 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.142379e-01 | 0.503 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.157989e-01 | 0.501 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.157989e-01 | 0.501 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.157989e-01 | 0.501 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.166306e-01 | 0.499 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.166306e-01 | 0.499 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.175727e-01 | 0.498 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.175727e-01 | 0.498 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.207810e-01 | 0.494 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.232501e-01 | 0.490 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.245482e-01 | 0.489 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.252902e-01 | 0.488 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.252902e-01 | 0.488 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.252902e-01 | 0.488 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.352730e-01 | 0.475 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.352730e-01 | 0.475 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.366856e-01 | 0.473 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.394555e-01 | 0.469 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.443573e-01 | 0.463 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.456153e-01 | 0.461 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.456153e-01 | 0.461 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.456153e-01 | 0.461 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.456153e-01 | 0.461 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.456153e-01 | 0.461 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 3.456153e-01 | 0.461 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.456153e-01 | 0.461 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.456153e-01 | 0.461 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.456153e-01 | 0.461 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.456153e-01 | 0.461 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.456153e-01 | 0.461 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.456153e-01 | 0.461 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.456153e-01 | 0.461 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 3.456153e-01 | 0.461 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.456153e-01 | 0.461 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.456153e-01 | 0.461 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.456153e-01 | 0.461 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.456153e-01 | 0.461 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.456153e-01 | 0.461 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.456153e-01 | 0.461 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.456153e-01 | 0.461 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.456264e-01 | 0.461 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.456264e-01 | 0.461 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.456264e-01 | 0.461 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.456264e-01 | 0.461 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 3.456264e-01 | 0.461 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.499181e-01 | 0.456 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 3.508068e-01 | 0.455 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.508068e-01 | 0.455 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.558088e-01 | 0.449 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.558088e-01 | 0.449 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.558088e-01 | 0.449 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.558088e-01 | 0.449 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.558088e-01 | 0.449 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.558088e-01 | 0.449 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.561979e-01 | 0.448 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.607578e-01 | 0.443 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.607578e-01 | 0.443 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.607578e-01 | 0.443 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.627954e-01 | 0.440 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.628579e-01 | 0.440 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.628579e-01 | 0.440 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.628579e-01 | 0.440 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.628579e-01 | 0.440 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.632743e-01 | 0.440 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.632743e-01 | 0.440 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 3.683308e-01 | 0.434 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.691383e-01 | 0.433 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.691383e-01 | 0.433 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.747135e-01 | 0.426 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.747135e-01 | 0.426 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.758453e-01 | 0.425 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.772975e-01 | 0.423 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.772975e-01 | 0.423 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.772975e-01 | 0.423 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.904873e-01 | 0.408 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.932477e-01 | 0.405 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.937460e-01 | 0.405 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.937460e-01 | 0.405 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.937460e-01 | 0.405 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 3.937460e-01 | 0.405 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.937460e-01 | 0.405 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 3.937460e-01 | 0.405 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.944115e-01 | 0.404 | 1 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.951604e-01 | 0.403 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.960755e-01 | 0.402 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.995366e-01 | 0.398 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.036480e-01 | 0.394 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.036480e-01 | 0.394 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.065459e-01 | 0.391 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.067579e-01 | 0.391 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.079661e-01 | 0.389 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.088146e-01 | 0.388 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.088146e-01 | 0.388 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.088146e-01 | 0.388 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.088146e-01 | 0.388 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.128291e-01 | 0.384 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.128291e-01 | 0.384 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 4.128291e-01 | 0.384 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.128291e-01 | 0.384 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.128291e-01 | 0.384 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.128291e-01 | 0.384 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.128291e-01 | 0.384 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.128291e-01 | 0.384 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.128291e-01 | 0.384 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.128291e-01 | 0.384 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.128291e-01 | 0.384 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.155446e-01 | 0.381 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.186335e-01 | 0.378 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.258606e-01 | 0.371 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.310735e-01 | 0.365 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.310735e-01 | 0.365 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.310735e-01 | 0.365 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.310735e-01 | 0.365 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.310735e-01 | 0.365 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.310735e-01 | 0.365 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.310735e-01 | 0.365 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.311929e-01 | 0.365 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.318846e-01 | 0.365 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.318846e-01 | 0.365 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.318846e-01 | 0.365 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.318846e-01 | 0.365 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.318846e-01 | 0.365 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 4.318846e-01 | 0.365 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.318846e-01 | 0.365 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.318846e-01 | 0.365 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.318846e-01 | 0.365 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.318846e-01 | 0.365 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.318846e-01 | 0.365 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.318846e-01 | 0.365 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 4.318846e-01 | 0.365 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.318846e-01 | 0.365 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.318846e-01 | 0.365 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.318846e-01 | 0.365 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.323478e-01 | 0.364 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.399928e-01 | 0.357 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.399928e-01 | 0.357 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.399928e-01 | 0.357 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.405747e-01 | 0.356 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.453451e-01 | 0.351 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.453451e-01 | 0.351 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.533263e-01 | 0.344 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.558701e-01 | 0.341 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.603884e-01 | 0.337 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.603884e-01 | 0.337 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.603884e-01 | 0.337 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.603884e-01 | 0.337 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.603884e-01 | 0.337 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.603884e-01 | 0.337 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.603884e-01 | 0.337 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.603884e-01 | 0.337 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.603884e-01 | 0.337 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.603884e-01 | 0.337 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 4.603884e-01 | 0.337 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.603884e-01 | 0.337 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.675313e-01 | 0.330 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.675313e-01 | 0.330 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.675313e-01 | 0.330 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.675313e-01 | 0.330 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.675313e-01 | 0.330 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.706682e-01 | 0.327 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.706682e-01 | 0.327 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.706682e-01 | 0.327 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.706682e-01 | 0.327 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.706682e-01 | 0.327 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.706682e-01 | 0.327 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.723328e-01 | 0.326 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.723328e-01 | 0.326 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.733515e-01 | 0.325 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.733515e-01 | 0.325 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.737777e-01 | 0.324 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.738485e-01 | 0.324 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.741652e-01 | 0.324 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.741652e-01 | 0.324 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.741652e-01 | 0.324 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.879926e-01 | 0.312 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.909177e-01 | 0.309 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.948128e-01 | 0.306 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.948128e-01 | 0.306 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.966033e-01 | 0.304 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.973468e-01 | 0.303 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.973468e-01 | 0.303 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 4.988846e-01 | 0.302 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.006980e-01 | 0.300 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.029071e-01 | 0.299 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.029071e-01 | 0.299 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.029071e-01 | 0.299 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.047717e-01 | 0.297 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.056173e-01 | 0.296 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 5.056173e-01 | 0.296 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 5.056173e-01 | 0.296 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.056173e-01 | 0.296 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.056173e-01 | 0.296 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 5.056173e-01 | 0.296 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 5.056173e-01 | 0.296 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.056173e-01 | 0.296 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.056173e-01 | 0.296 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.056173e-01 | 0.296 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.056173e-01 | 0.296 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.056173e-01 | 0.296 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.067851e-01 | 0.295 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.067851e-01 | 0.295 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.067851e-01 | 0.295 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.067851e-01 | 0.295 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.067851e-01 | 0.295 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.067851e-01 | 0.295 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5683678 | 5.067851e-01 | 0.295 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.067851e-01 | 0.295 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.067851e-01 | 0.295 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5688399 | 5.067851e-01 | 0.295 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.067851e-01 | 0.295 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 5.067851e-01 | 0.295 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 5.067851e-01 | 0.295 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.067851e-01 | 0.295 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.067851e-01 | 0.295 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.067851e-01 | 0.295 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.067851e-01 | 0.295 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.117703e-01 | 0.291 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.166028e-01 | 0.287 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.210159e-01 | 0.283 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.249085e-01 | 0.280 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.249085e-01 | 0.280 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.299600e-01 | 0.276 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.319260e-01 | 0.274 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.370323e-01 | 0.270 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.393676e-01 | 0.268 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.442312e-01 | 0.264 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.442312e-01 | 0.264 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.449073e-01 | 0.264 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.449073e-01 | 0.264 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.449073e-01 | 0.264 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.483035e-01 | 0.261 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.483035e-01 | 0.261 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.483035e-01 | 0.261 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.483035e-01 | 0.261 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.483035e-01 | 0.261 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.483035e-01 | 0.261 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.483035e-01 | 0.261 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.583521e-01 | 0.253 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.644410e-01 | 0.248 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.669351e-01 | 0.246 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.669351e-01 | 0.246 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.697778e-01 | 0.244 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.697778e-01 | 0.244 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.697778e-01 | 0.244 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.697778e-01 | 0.244 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.718145e-01 | 0.243 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.718145e-01 | 0.243 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.718145e-01 | 0.243 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 5.718145e-01 | 0.243 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.718145e-01 | 0.243 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.718145e-01 | 0.243 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.718145e-01 | 0.243 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.718145e-01 | 0.243 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.718145e-01 | 0.243 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.750616e-01 | 0.240 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 5.825710e-01 | 0.235 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 5.857907e-01 | 0.232 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.857907e-01 | 0.232 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.883315e-01 | 0.230 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.883315e-01 | 0.230 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.883315e-01 | 0.230 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.883315e-01 | 0.230 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.883315e-01 | 0.230 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.883315e-01 | 0.230 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.010497e-01 | 0.221 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.010497e-01 | 0.221 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.010497e-01 | 0.221 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.010497e-01 | 0.221 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.106148e-01 | 0.214 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.122097e-01 | 0.213 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.122097e-01 | 0.213 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.122218e-01 | 0.213 | 1 | 0 |
| Protein localization | R-HSA-9609507 | 6.222514e-01 | 0.206 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.222802e-01 | 0.206 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.256600e-01 | 0.204 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.256600e-01 | 0.204 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.256600e-01 | 0.204 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.256600e-01 | 0.204 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.256600e-01 | 0.204 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.256600e-01 | 0.204 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 6.282731e-01 | 0.202 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.282731e-01 | 0.202 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.282731e-01 | 0.202 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.282731e-01 | 0.202 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.282731e-01 | 0.202 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.282731e-01 | 0.202 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.282731e-01 | 0.202 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.282731e-01 | 0.202 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.282731e-01 | 0.202 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.282731e-01 | 0.202 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.282731e-01 | 0.202 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.282731e-01 | 0.202 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.282731e-01 | 0.202 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.282731e-01 | 0.202 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.282731e-01 | 0.202 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.307848e-01 | 0.200 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.307848e-01 | 0.200 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.307848e-01 | 0.200 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.307848e-01 | 0.200 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.307848e-01 | 0.200 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.315107e-01 | 0.200 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.346444e-01 | 0.197 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.375592e-01 | 0.195 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.375592e-01 | 0.195 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.375592e-01 | 0.195 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.410511e-01 | 0.193 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.446747e-01 | 0.191 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.460354e-01 | 0.190 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.517351e-01 | 0.186 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.517351e-01 | 0.186 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.517351e-01 | 0.186 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.586046e-01 | 0.181 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.589468e-01 | 0.181 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.589468e-01 | 0.181 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.589468e-01 | 0.181 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.589468e-01 | 0.181 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.603051e-01 | 0.180 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 6.603051e-01 | 0.180 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.603051e-01 | 0.180 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.603051e-01 | 0.180 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.603051e-01 | 0.180 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.603051e-01 | 0.180 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 6.603051e-01 | 0.180 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 6.603051e-01 | 0.180 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.603051e-01 | 0.180 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.603051e-01 | 0.180 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.618038e-01 | 0.179 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.618038e-01 | 0.179 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.618038e-01 | 0.179 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.618038e-01 | 0.179 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.649828e-01 | 0.177 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.662171e-01 | 0.176 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.765560e-01 | 0.170 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.772902e-01 | 0.169 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.772902e-01 | 0.169 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.772902e-01 | 0.169 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.772902e-01 | 0.169 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.772902e-01 | 0.169 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.772902e-01 | 0.169 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.772902e-01 | 0.169 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.772902e-01 | 0.169 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.772902e-01 | 0.169 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.772902e-01 | 0.169 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.772902e-01 | 0.169 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.772902e-01 | 0.169 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.772902e-01 | 0.169 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.772902e-01 | 0.169 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.772902e-01 | 0.169 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.772902e-01 | 0.169 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.772902e-01 | 0.169 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.772902e-01 | 0.169 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.772902e-01 | 0.169 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.772902e-01 | 0.169 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.772902e-01 | 0.169 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.777762e-01 | 0.169 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.849216e-01 | 0.164 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.849216e-01 | 0.164 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.849216e-01 | 0.164 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.855222e-01 | 0.164 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.855222e-01 | 0.164 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.855222e-01 | 0.164 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.855222e-01 | 0.164 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.868866e-01 | 0.163 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.900801e-01 | 0.161 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.900801e-01 | 0.161 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.900801e-01 | 0.161 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.923252e-01 | 0.160 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.923252e-01 | 0.160 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.923252e-01 | 0.160 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.923252e-01 | 0.160 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.935405e-01 | 0.159 | 0 | 0 |
| Translation | R-HSA-72766 | 6.939706e-01 | 0.159 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.986530e-01 | 0.156 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.067378e-01 | 0.151 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.069021e-01 | 0.151 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.069021e-01 | 0.151 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.069021e-01 | 0.151 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.069021e-01 | 0.151 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.105165e-01 | 0.148 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.105165e-01 | 0.148 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.106347e-01 | 0.148 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.111196e-01 | 0.148 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.136621e-01 | 0.147 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.169150e-01 | 0.145 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 7.198462e-01 | 0.143 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.198462e-01 | 0.143 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.198462e-01 | 0.143 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.198462e-01 | 0.143 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.198462e-01 | 0.143 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.198462e-01 | 0.143 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 7.198462e-01 | 0.143 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 7.198462e-01 | 0.143 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.198462e-01 | 0.143 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.198462e-01 | 0.143 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.198462e-01 | 0.143 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.218102e-01 | 0.142 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.218102e-01 | 0.142 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.218102e-01 | 0.142 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.255266e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.255616e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.255616e-01 | 0.139 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.269094e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.339514e-01 | 0.134 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.339514e-01 | 0.134 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.433282e-01 | 0.129 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.474598e-01 | 0.126 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.474598e-01 | 0.126 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.488717e-01 | 0.126 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.488717e-01 | 0.126 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 7.488717e-01 | 0.126 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.488717e-01 | 0.126 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.488717e-01 | 0.126 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 7.488717e-01 | 0.126 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.551319e-01 | 0.122 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.558614e-01 | 0.122 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.558614e-01 | 0.122 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.558614e-01 | 0.122 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.558614e-01 | 0.122 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.558614e-01 | 0.122 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.558614e-01 | 0.122 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.567925e-01 | 0.121 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.567925e-01 | 0.121 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.567925e-01 | 0.121 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.567925e-01 | 0.121 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.567925e-01 | 0.121 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.567925e-01 | 0.121 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.567925e-01 | 0.121 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.567925e-01 | 0.121 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.567925e-01 | 0.121 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 7.567925e-01 | 0.121 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.567925e-01 | 0.121 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.567925e-01 | 0.121 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.567925e-01 | 0.121 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.567925e-01 | 0.121 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.567925e-01 | 0.121 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.567925e-01 | 0.121 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.567925e-01 | 0.121 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.572223e-01 | 0.121 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.580310e-01 | 0.120 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.596089e-01 | 0.119 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.609809e-01 | 0.119 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.633186e-01 | 0.117 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.660626e-01 | 0.116 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 7.731850e-01 | 0.112 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.736361e-01 | 0.111 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.736361e-01 | 0.111 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.736361e-01 | 0.111 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.736361e-01 | 0.111 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.736361e-01 | 0.111 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.743690e-01 | 0.111 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.762913e-01 | 0.110 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.762913e-01 | 0.110 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.762913e-01 | 0.110 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.762913e-01 | 0.110 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.762913e-01 | 0.110 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.810168e-01 | 0.107 | 1 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.839845e-01 | 0.106 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.839845e-01 | 0.106 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.876167e-01 | 0.104 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.888682e-01 | 0.103 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.888682e-01 | 0.103 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.888682e-01 | 0.103 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.888682e-01 | 0.103 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.888682e-01 | 0.103 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.888682e-01 | 0.103 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.948257e-01 | 0.100 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.952940e-01 | 0.099 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.952940e-01 | 0.099 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.952940e-01 | 0.099 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.952940e-01 | 0.099 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.952940e-01 | 0.099 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.962385e-01 | 0.099 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.962385e-01 | 0.099 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.011891e-01 | 0.096 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.013373e-01 | 0.096 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.129286e-01 | 0.090 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.129286e-01 | 0.090 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.154558e-01 | 0.089 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.167151e-01 | 0.088 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.167151e-01 | 0.088 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.167151e-01 | 0.088 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 8.167151e-01 | 0.088 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 8.167151e-01 | 0.088 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.167151e-01 | 0.088 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.167151e-01 | 0.088 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.167151e-01 | 0.088 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.168183e-01 | 0.088 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.168183e-01 | 0.088 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.168183e-01 | 0.088 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.197948e-01 | 0.086 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.220776e-01 | 0.085 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.248308e-01 | 0.084 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.264061e-01 | 0.083 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.292581e-01 | 0.081 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.292581e-01 | 0.081 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.297119e-01 | 0.081 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.298903e-01 | 0.081 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.298903e-01 | 0.081 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.312640e-01 | 0.080 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.326967e-01 | 0.080 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.355158e-01 | 0.078 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.355158e-01 | 0.078 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.355158e-01 | 0.078 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.355158e-01 | 0.078 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.355158e-01 | 0.078 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.355158e-01 | 0.078 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.399681e-01 | 0.076 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.408907e-01 | 0.075 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.408907e-01 | 0.075 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.408907e-01 | 0.075 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.408907e-01 | 0.075 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.408907e-01 | 0.075 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.408907e-01 | 0.075 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.409233e-01 | 0.075 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.416125e-01 | 0.075 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.443486e-01 | 0.073 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.454752e-01 | 0.073 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.465738e-01 | 0.072 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.524694e-01 | 0.069 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.524694e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.524694e-01 | 0.069 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.524694e-01 | 0.069 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.524694e-01 | 0.069 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.524694e-01 | 0.069 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.559427e-01 | 0.068 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.559427e-01 | 0.068 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.582675e-01 | 0.066 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.582675e-01 | 0.066 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.582675e-01 | 0.066 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.582675e-01 | 0.066 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.582675e-01 | 0.066 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.592425e-01 | 0.066 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.618786e-01 | 0.065 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.618786e-01 | 0.065 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.618786e-01 | 0.065 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.618786e-01 | 0.065 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.618786e-01 | 0.065 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.618786e-01 | 0.065 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.618786e-01 | 0.065 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.618786e-01 | 0.065 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.618786e-01 | 0.065 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.618786e-01 | 0.065 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.635765e-01 | 0.064 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.641500e-01 | 0.063 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.710828e-01 | 0.060 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.726131e-01 | 0.059 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.726131e-01 | 0.059 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.785174e-01 | 0.056 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.800991e-01 | 0.055 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.800991e-01 | 0.055 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.800991e-01 | 0.055 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.800991e-01 | 0.055 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.800991e-01 | 0.055 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.816782e-01 | 0.055 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.816782e-01 | 0.055 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.816782e-01 | 0.055 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.828620e-01 | 0.054 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.886077e-01 | 0.051 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.936717e-01 | 0.049 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.941862e-01 | 0.049 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 8.941862e-01 | 0.049 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.944226e-01 | 0.048 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.958063e-01 | 0.048 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.959170e-01 | 0.048 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.959170e-01 | 0.048 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.959170e-01 | 0.048 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.959170e-01 | 0.048 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.959170e-01 | 0.048 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.959170e-01 | 0.048 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.959170e-01 | 0.048 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.959170e-01 | 0.048 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.979570e-01 | 0.047 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.979570e-01 | 0.047 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.979570e-01 | 0.047 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.986753e-01 | 0.046 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.054543e-01 | 0.043 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.054543e-01 | 0.043 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 9.096488e-01 | 0.041 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 9.096488e-01 | 0.041 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.096488e-01 | 0.041 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.096488e-01 | 0.041 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.096488e-01 | 0.041 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.096488e-01 | 0.041 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.104585e-01 | 0.041 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.115339e-01 | 0.040 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.116766e-01 | 0.040 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.146013e-01 | 0.039 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.155919e-01 | 0.038 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.171419e-01 | 0.038 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 9.215697e-01 | 0.035 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.215697e-01 | 0.035 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.215697e-01 | 0.035 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.215697e-01 | 0.035 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 9.215697e-01 | 0.035 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.215697e-01 | 0.035 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.215697e-01 | 0.035 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.215697e-01 | 0.035 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.215697e-01 | 0.035 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.215697e-01 | 0.035 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.215697e-01 | 0.035 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.241499e-01 | 0.034 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.284782e-01 | 0.032 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.284782e-01 | 0.032 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.293540e-01 | 0.032 | 1 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.312164e-01 | 0.031 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.319184e-01 | 0.031 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.319184e-01 | 0.031 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.319184e-01 | 0.031 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 9.319184e-01 | 0.031 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 9.319184e-01 | 0.031 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.319184e-01 | 0.031 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.319184e-01 | 0.031 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.319184e-01 | 0.031 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.319184e-01 | 0.031 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.328766e-01 | 0.030 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.328766e-01 | 0.030 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.328766e-01 | 0.030 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.328766e-01 | 0.030 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.328766e-01 | 0.030 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.350373e-01 | 0.029 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.350373e-01 | 0.029 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.356754e-01 | 0.029 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.356754e-01 | 0.029 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.402063e-01 | 0.027 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.402063e-01 | 0.027 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.409021e-01 | 0.026 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.409021e-01 | 0.026 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.409021e-01 | 0.026 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.409021e-01 | 0.026 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.409021e-01 | 0.026 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.409021e-01 | 0.026 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.409021e-01 | 0.026 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.452614e-01 | 0.024 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.466713e-01 | 0.024 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.467709e-01 | 0.024 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.467709e-01 | 0.024 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.467709e-01 | 0.024 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.467709e-01 | 0.024 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.472813e-01 | 0.024 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.473394e-01 | 0.023 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.487008e-01 | 0.023 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.487008e-01 | 0.023 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.487008e-01 | 0.023 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.487008e-01 | 0.023 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.487008e-01 | 0.023 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.487008e-01 | 0.023 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.487008e-01 | 0.023 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.500618e-01 | 0.022 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.525195e-01 | 0.021 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.525195e-01 | 0.021 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.526448e-01 | 0.021 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.539584e-01 | 0.020 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.554707e-01 | 0.020 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.554707e-01 | 0.020 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.554707e-01 | 0.020 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 9.554707e-01 | 0.020 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.554707e-01 | 0.020 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.572202e-01 | 0.019 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.572202e-01 | 0.019 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.583706e-01 | 0.018 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.592571e-01 | 0.018 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.613476e-01 | 0.017 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.613476e-01 | 0.017 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.613476e-01 | 0.017 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.620556e-01 | 0.017 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.625860e-01 | 0.017 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.664492e-01 | 0.015 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.664492e-01 | 0.015 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.664492e-01 | 0.015 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.664492e-01 | 0.015 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.664492e-01 | 0.015 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.664492e-01 | 0.015 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.667719e-01 | 0.015 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.688348e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.688348e-01 | 0.014 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.708776e-01 | 0.013 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.708776e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.708776e-01 | 0.013 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.708776e-01 | 0.013 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.716708e-01 | 0.012 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.719929e-01 | 0.012 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.719929e-01 | 0.012 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.719929e-01 | 0.012 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.732819e-01 | 0.012 | 1 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.733924e-01 | 0.012 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.738318e-01 | 0.012 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.747218e-01 | 0.011 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.747218e-01 | 0.011 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.747218e-01 | 0.011 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.747218e-01 | 0.011 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.747218e-01 | 0.011 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.747218e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.747218e-01 | 0.011 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.767945e-01 | 0.010 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.767945e-01 | 0.010 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.774215e-01 | 0.010 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.774783e-01 | 0.010 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.780587e-01 | 0.010 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.780587e-01 | 0.010 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.780587e-01 | 0.010 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.780587e-01 | 0.010 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.785417e-01 | 0.009 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.789197e-01 | 0.009 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.794312e-01 | 0.009 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.794312e-01 | 0.009 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.799747e-01 | 0.009 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.809553e-01 | 0.008 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.809553e-01 | 0.008 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.815755e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.817764e-01 | 0.008 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.818385e-01 | 0.008 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.818385e-01 | 0.008 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.818385e-01 | 0.008 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.827753e-01 | 0.008 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.834022e-01 | 0.007 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.834697e-01 | 0.007 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.834697e-01 | 0.007 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.834697e-01 | 0.007 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.834697e-01 | 0.007 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.834697e-01 | 0.007 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.837244e-01 | 0.007 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.838610e-01 | 0.007 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.838610e-01 | 0.007 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.853137e-01 | 0.006 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.856522e-01 | 0.006 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.856522e-01 | 0.006 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.856522e-01 | 0.006 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.856522e-01 | 0.006 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.857130e-01 | 0.006 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.863140e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.864229e-01 | 0.006 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.864229e-01 | 0.006 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.866597e-01 | 0.006 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.875467e-01 | 0.005 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.875467e-01 | 0.005 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.875467e-01 | 0.005 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.875467e-01 | 0.005 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.875467e-01 | 0.005 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.881847e-01 | 0.005 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.891911e-01 | 0.005 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.895545e-01 | 0.005 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.901114e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.906184e-01 | 0.004 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.906184e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.906184e-01 | 0.004 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.906184e-01 | 0.004 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.912591e-01 | 0.004 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.912591e-01 | 0.004 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.916550e-01 | 0.004 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.922762e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.929328e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.929328e-01 | 0.003 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.929328e-01 | 0.003 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.929328e-01 | 0.003 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.929328e-01 | 0.003 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.930792e-01 | 0.003 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.932415e-01 | 0.003 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.938662e-01 | 0.003 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.940020e-01 | 0.003 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.942309e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.945436e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.946812e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.947005e-01 | 0.002 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.953796e-01 | 0.002 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.953796e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.957867e-01 | 0.002 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.959127e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.959899e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.960800e-01 | 0.002 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.962453e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.965197e-01 | 0.002 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.965197e-01 | 0.002 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.965197e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.965197e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.966551e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.966551e-01 | 0.001 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.969795e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.971603e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.973094e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.973786e-01 | 0.001 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.973786e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.973786e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.973786e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.977947e-01 | 0.001 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.980256e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.980256e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.980256e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.982140e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.982865e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.985129e-01 | 0.001 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.987095e-01 | 0.001 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.987095e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.988352e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.988366e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.989541e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.989548e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.989656e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.990153e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.990281e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.991565e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.992051e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.992680e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.993648e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.995826e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.996007e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996066e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.996874e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997170e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997170e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997170e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.997209e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.997288e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998090e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.998318e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.998462e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998532e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998695e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.998842e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998863e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999316e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999327e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.999327e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.999344e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999344e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999431e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999472e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.999507e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999571e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999660e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999667e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999719e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999757e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999789e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.999789e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999841e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999862e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999862e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999862e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999881e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999896e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999922e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999946e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999949e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999967e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999972e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999988e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999992e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999992e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999994e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999994e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999995e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999998e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999998e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999998e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 1 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |